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Gene regulation is fundamental to cellular function. Neuronal differentiation is a 
critical process that involves precise regulation of many genes. microRNAs 
(miRNAs) have been found to be essential regulators of many biological processes 
including neuronal differentiation through their sequence-specific modulation of gene 
expression. Reverse transcription-quantitative PCR (RT-qPCR) is an established, 
sensitive and accurate platform for gene (both genomic and mRNA) quantitation. RT-
qPCR has also been successfully applied to the quantification of miRNA. RT-qPCR 
or any other approach to gene quantification is dependent on valid comparisons 
between and/or within samples. Such comparisons most commonly involve 
comparison of the detected abundance gene(s) of interest against that of an 
endogenous reference gene. However, without a priori evidence of the stability of a 
reference gene, it is possible that interpretation of gene expression data could result in 
erroneous conclusions of gene regulation. It is therefore imperative to empirically 
determine the suitability of reference genes in any given experimental model. 
 
This work begins with the selection and use of endogenous reference genes for 
mRNA and miRNA studies in neuronal differentiation. Transcriptome-wide sampling 
supplemented by RT-qPCR gene quantification was used to empirically compare the 
stability of commonly used reference genes against novel reference genes. It emerged 
that mRNAs encoding ribosomal proteins but not popular reference genes such as 
GAPDH were stable reference genes in neuronal differentiation.  
 
To detect and quantify miRNAs, a RT-qPCR method previously used to quantify 
flaviviruses was adapted. This method was named modified stem-loop mediated 
VI 
reverse transcription-quantitative PCR (mSMRT-qPCR) and applied to the 
determination of stable miRNAs in neuronal quantification.  We found that using a set 
of three miRNAs provided a more stable reference than the commonly used 
references snoU6 and 5S RNA. 
 
Finally, methods are described to adapt a qPCR buffer mixture for reverse 
transcription and to computationally aid designs of mSMRT-qPCR miRNA assays. 
The adapted reverse transcription buffer mixture is inherently compatible with 
downstream qPCR applications and benefits from the absence of PCR inhibitors such 
as dithiotreitol. To aid in the design and organization of a larger set of mSMRT-qPCR 
primer designs, a design platform was implemented using Microsoft Excel. miRNA 
assays designed using this platform were successfully used to detect miRNAs from 
both isolated RNA and whole cell lysate.   
VII 
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 : Introduction Chapter 1
 
1.1 Neuronal Differentiation 
 
In development, cells destined to be neurons must execute a finely controlled genetic 
program to acquire their neuronal identity. During this process of neuronal 
differentiation, cells undergo interlinked changes at the epigenetic, transcriptional and 
proteomic levels [1-3]. In embryonic stem cells (ESCs) chromatin modification and 
promoter site occupancy patterns change dramatically during the process of in vitro 
differentiation into neural stem cells (NSCs) [4] and further into specific neuron 
lineages [5, 6]. These changes are discrete, specific local heterochromatin markings 
[7] that repress the expression of anti-neurogenic genes while promoting pro-neuronal 
differentiation genes [5]. These remarkably precise changes are regulated by a 
complement of external factors as well as internal regulators. 
 
Nerve growth factor (NGF) is a prototypical example of a growth factor which 
mediates dramatic effects on protein and RNA synthesis as well as cellular 
metabolism and morphology in neuronal differentiation [8]. As the first neuronal 
growth factor to be identified, the inquiry into the functions of NGF was to  lay the 
foundations for future studies into nerve cells and the targets they innervated [9]. It 
came to light that cellular responses to NGF was determined by the expression of 
specific receptors TrkA and p75NTR. Activation of TrkA by NGF generally promoted 
cell survival and differentiation, activation of p75NTR
 
in the absence of TrkA resulted 
in cell death [10]. These studies shed significant insight into the ability of neuronal 
cells to contextualize external signals through the expression of distinct gene 
products. As a potent neurotrophic factor, NGF is involved in a wide spectrum of 
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physiological functions [11]. Dysregulation of NGF has been linked to the 
neuropathology of Alzheimer’s disease and NGF currently remains of great research 
interest some 60 years after its discovery [12]. 
 
NGF is only one of a plethora of factors modulating the process of neuronal 
differentiation. It is now accepted that the pleiotropic effects of neurotrophic agents 
can in part be attributed to interactions with alternatively spliced forms of the same 
receptor [reviewed in 13]. Glial cell line-derived neurotropic factor (GDNF) was first 
isolated based on its ability to specifically promote midbrain dopaminergic neuron 
survival [14] and  has raised much interest as a potential therapeutic for Parkinson’s 
disease [15] and brain injury [16]. GDNF is a member of a family of four cysteine 
knot neuronal growth factors comprising GDNF, neuturin (NTN), persephin and 
artemin collectively known as the GDNF family of ligands (GFL). Each GFL signals 
through its preferred receptors termed GFL receptor alpha 1-4 (GFRα1-4) and the 
trans-membrane tyrosine kinase RET. Interestingly, GDNF and NTN are also able to 
bind to the spliced isoforms of GFRα1 and GFRα2 with functionally distinct 
consequences [17, 18] and there are indications that spliced isoforms of its co-
receptor RET may also mediate distinct functions [19, 20]. As more interacting 
partners which affect signaling are found, the degree of complexity underlying GFL-
mediated neuronal differentiation alone increases tremendously (Figure 1.1). Studying 
the combinatorial complexity that underlies neuronal differentiation thus requires 




Figure 1.1. Simplified aspects of GFL-GFRα mediated signaling. Cross talk and partner receptors 
modulate the cascade of events arising from specific ligand-receptor complex interactions. In neuronal 
differentiation, (1) signal transduction triggers transcription of pro-differentiation genes, (2) while also 
suppressing anti-differentiation gene products. (3) Pro-differentiation gene products may contribute to 
a feed-forward mechanism by suppressing/promoting degradation of anti-differentiation gene products 
or activating effector proteins. Adapted from [21]. 
 
Transcription profiling is often used as the first step to elucidate complex biological 
processes. A common goal of these studies of this nature is to investigate the import 
of gene abundance on the process involved. The central role of transcription in 
neuronal differentiation has been clearly demonstrated in recent studies where somatic 
fibroblasts were demonstrably reprogrammed into neuronal phenotypes through 








more recently sequencing studies have proved to be powerful windows into the 
dynamic transcriptional circuitry driving neuronal differentiation [25, 26]. Given the 
thousands of transcripts simultaneously screened in these techniques the probability of 
false negatives calls for confirmation of regulation using an independent technique. 
Thus, the massively parallel sampling of activated and repressed genes afforded by 
microarray and sequencing approaches is typically validated by more sensitive and 
accurate measurements using RT-qPCR (reverse transcription-quantitative 
polymerase chain reaction) [25, 26]. In recent years, the value of transcriptional 
studies has been reaffirmed as the importance of non-coding species of RNAs in 
many cellular processes has come to light. One class of these RNAs, microRNAs 




miRNAs are highly conserved 18-22 nucleotide (nt) RNAs that  regulate gene 
expression in a sequence-specific manner [28]. miRNAs have been found to 
contribute to the regulation of cell proliferation, viability, migration and 
differentiation in a wide variety of tissues and cell types [29-33]. It has been estimated 
that more than half of the protein-coding genes in the human genome selective are 
under pressure to maintain miRNA target sites [34]. The involvement of miRNAs in 
pathological processes has also raised the possibility of miRNA based therapies [35, 
36] while miRNAs found in blood circulation and exosomes may be potential 
biomarkers [37]. To date, more than 16,000 entries for over 60 organisms have been 
made in miRbase (Release 17, April 2011), the central repository of miRNA 




miRNAs differ from other small RNAs in their biogenesis [39]. Although there may 
be other possible mechanisms that may give rise to miRNA and miRNA-like species 
[40], the generally accepted biogenesis and mode of action are as follows (Figure 1.2). 
RNA polymerase II transcribes poly-A tailed primary transcripts (pri-miRNAs) that 
may or may not be part of a protein-coding transcript. It thus follows that expression 
of intragenic miRNAs may be under the control of a common promoter as its host 
gene; alternatively, internal promoters may control miRNA function independently of 
its host gene [41]. These pri-miRNAs can contain one or more miRNA precursors 
(e.g. the miR-17-92 cluster in humans which contains six known precursor miRNAs). 
This precursor miRNA (pre-miRNA) is typically a 60-70 nt hairpin. The precursor 
miRNA is released from the primary transcript within the nucleus through the 
RNAase III activity of the Drosha/DGCR8 complex. As of miRBase version 17, 1492 
human miRNA precursors have been mapped to the genome. Precursor miRNA is 
exported to the cytoplasm via Exportin and Ran-GTPase. Dicer, a type III RNase then 
cleaves the hairpin and assists in associating the resulting mature miRNA into the 
RNA-induced silencing complex (RISC).  
 
The RISC complex targets the 3’ un-translated region (UTR) of mRNA sequences 
with either perfect or imperfect complementary to the miRNA. While the exact rules 
of target specificity has not yet been determined, it is believed that the 5 to 7 
nucleotides (the ‘seed region’) at the 5’ end of the miRNA determine RISC binding 
[42]. There are now numerous algorithms to predict miRNA targets [42-44].  Once 
bound, the RISC complex may either terminate the translation of its target or promote 
its degradation. This process appears to involve many proteins including the SMAD 
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family of proteins [45, 46] and thus appears itself tightly regulated [47]. Recent 
findings suggest that the predominant activity of miRNA-mediated RISC activity 
results preferentially in target degradation [27]. The direct impact of miRNAs on 
target mRNA levels allows cells to quickly adjust the pool of mRNA available for 
translation at any given moment. Intriguingly, miR-10a was found to bind to the 5’ 
UTR of ribosomal protein mRNA and enhanced its translation [48]. Whether this 
example of miRNA enhancing translation is an oddity or an as-yet unappreciated 
general mechanism remains to be seen, but highlights the nascent state of our 
understanding of miRNA biology. The action of miRNAs underscores the regulatory 
complexity belying the central dogma of biology and has certainly added another 
dimension to our understanding of neuronal differentiation.  
 
Figure 1.2 Outline of miRNA biogenesis and mode of action. The figure shows hsa-miR-1 



















1.3 miRNA in Neuronal Differentiation 
 
The first miRNA to be described, let-7 [50] in C. Elegans, controls neuronal 
differentiation. In higher organisms, Dicer function is essential for proper neural 
development [51-53]. miRNAs are important effectors of neuronal differentiation [3, 
54] and miRNA expression profiles change drastically during the course of neuronal 
differentiation [50, 55], as may be expected from the specific gene regulation required 
during the execution of the differentiation program. Coordinated miRNA regulation 
during neuronal differentiation directly represses mRNAs antagonistic to neuronal 
differentiation [56-59]. For instance, miR-125b has been shown to directly target 
genes regulating differentiation such as TBC1D1 and ITCH [56]. More recently, miR-
10a and miR-10b have been shown to regulate SFS2 [60] and NCOR2 [61] during 
neuronal differentiation. Conversely, the down-regulation of miR-17/20a during 
neuronal differentiation resulted in increased levels of pro-differentiation genes 
BCL2, MEF2D and MAP3K12 [62].  
 
The best studied miRNAs associated with neuronal differentiation are miR-124 and 
miR-9. During neuronal differentiation, miR-124 actively suppresses transcription of 
anti-neurogenic REST (repression element-1 silencing transcription factor) [63]. 
Inhibiting the activity of miR-124 in differentiated neurons resulted in an increase in 
the levels of non-neuronal mRNA transcripts detected in the cells [64]. These non-
neuronal genes are either relatively less abundant or not detectable in neuronal cells. 
Taken together, miR-124 thus functions as an important effector of the neuronal 
differentiation program through its repression of REST [64]. A second mechanism 
through which miR-124 promotes neuronal differentiation is through repression of the 
splicing factor PTBP1 (polypyrimidine tract binding protein 1) [65]. PTBP1 represses 
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pro-neuronal PTBP2 by splicing its mRNA transcript so as to promote its nonsense-
mediated degradation. Increase in miR-124 levels represses PTBP1 and allows 
translation of PTBP2, which promoted neuronal identity [65].  A recent study found 
miR-124 to be essential in the direct conversion of somatic fibroblasts into functional 
neurons, a clear demonstration of its pivotal role in the process of neuronal 
differentiation [22].  
 
The antagonistic relationship between the stem cell renewal transcription factor TLX 
and neuronal miRNAs miR-9 and miR-9* [66] also serves to illustrate the impact of 
miRNAs on neuronal differentiation. The transcription of miR-9 has been attributed to 
retinoic acid induced CREB transcriptional activity, and REST has also been found to 
be a target of miR-9 [59]. Interestingly, although TLX represses neuronal 
differentiation, its presence potentiates neuronal cells to respond to retinoic acid 
through up-regulation of the retinoic acid receptor RARβ [67]. miR-124 and miR-9 
are only two of many miRNAs (Figure 1.3) that have been found to contribute to 
various aspects of neuronal differentiation (Table 1.1). In addition,  the biological 
activity and regulation of miR-124 and miR-9 have proven to be context-specific in 
neuronal differentiation [33], a feature that can be expected in many more neuronal 
miRNAs. Intriguingly, there is also growing evidence that the RISC complex may 
also be active at distal neural sites such as neurites [53, 68-70]. This suggests that 
miRNA action may have roles in sculpturing fine neuronal structures such as dendritic 
spines [71] and synapse activity [72].  
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Figure 1.3 Involvement of miRNAs in control of neuronal differentiation. miR-9 and miR-124 
promote neuronal differentiation by repressing REST and TLX.  
 
 
Table 1.1 A brief survey of miRNAs involved in neuronal differentiation. 
 
microRNA Functional Domain Reference Comment 
miR-338 Regulates antagonistic genes NOVA and 
UBE2Q1 
[73] Hosted by AATK gene 
miR-124 Regulates pro-neuronal alternative 
splicing  factor PTBP2 
 [74] [75]  
 Essential for neuronal reprogramming of 
somatic cells 
[22]  
miR-200 Regulates olfactory neurogenesis [76]  
miR-138 Dendritic spine formation [71] Represses APT1 
miR-21  [77]  
miR-219 Oligodendrocyte differentiation [78] Represses pro-proliferation 
proteins PDGFα, Sox6, 
FoxJ3 and ZFP238 
miR-206 Neurotransmitter synthesis [79] Represses Tac1 to promote 
production of Substance P 
miR-125b promotes neuronal differentiation in SH-
SY5Y cells in RA-BDNF treatment 
[56] , possibly by repressing 




Regulates BIM [81] Represses differentiation 
miR221/222 Regulates BCL [82] Highly induced by NGF 
miR-222 ? [70] Localized in distal axons 
miR-132 CREB and modulates p250 to promote 
neuronal differentiation, 
[58] spine remodelling 
miR-9 Regulates stem cell renewal factor TLX [66]  
 
 
The intimate and dynamic relationship between miRNAs and their target mRNAs are 
compelling motivations for a transcriptomic approach to investigations into neuronal 
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differentiation. However, in order for valid biological conclusions to be made, the 
methods and assumptions underlying the quantifications need to be examined 
critically.  
1.4 Normalization of mRNA and miRNA Quantification 
 
In any quantification technique, it is necessary to minimize the effect of technical 
variations on measurements before valid conclusions can be drawn. In transcription 
profiling, this process of normalization is often done through the quantification of an 
endogenous reference gene. The expressions of the gene(s) of interest are then scaled 
to the relative detection of the reference gene in each sample before being compared. 
The approach of using an endogenous reference gene has the benefit of accounting for 
mRNA fraction variances in total RNA [83] and overall RNA quality [84] and is 
widely used in RT-qPCR [85-88]. It was common to use the relative expression of an 
abundant “housekeeping gene” in order to compare any changes in the expression of a 
transcript of interest. “Housekeeping genes” were selected based on their putative 
essential functions in cells and included genes such as glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) and beta-actin (ACTB) [83]. Such genes are usually highly 
expressed in cells and served as convenient indicators, or so it was thought, of 
equivalent RNA input in techniques such as Northern blotting. The underlying 
assumptions behind the selection of housekeeping genes as reference genes are that 
these genes are universally expressed at invariant levels across various cell types and 
cellular processes.  
 
However, this approach to selection of reference genes is fundamentally flawed. 
Putatively “housekeeping” functions may themselves be regulated in the course of a 
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biological process or in particular cell types. “Housekeeping” genes has been found to 
vary widely across physiological tissues [89] and in pathological processes such as 
breast cancer [90] and neurogenerative diseases such as Parkinson’s and Alzheimer’s 
disease. [88]. The choice of a reference gene thus cannot be based solely on a priori 
assumptions of stable gene expression based solely on putative gene function.  
 
Given the role of miRNAs in mRNA regulation, it was also natural for expressions of 
miRNA to be quantified. In miRNA quantification as in mRNA quantification, RT-
qPCR remains the most sensitive and accurate quantification platform [91, 92]. 
However, due to their small size and presence of precursors containing the identical 
sequence in total RNA, miRNA quantification presents additional challenges. 
Furthermore, traditional small RNA loading controls such as snoU6 and 5S RNA 
have been carried over as reference genes for miRNA quantification for similar 
reasons as GAPDH and ACTB – assumed invariant expression based on ubiquity and 
high expression levels. Due to their small size, miRNA quantification can be affected 
by RNA isolation techniques which discriminate based on size [93, 94]. While closer 
in size to miRNAs than typical mRNA transcripts, snoU6 (106 nt) and 5S RNA (121 
nt) are still significantly larger molecules than miRNAs (~20 nt), which poses yet 
more considerations for sample preparation. It is thus desirable for an endogenous, 
stably expressed miRNA, if one can be found, to be used as an expression reference.   
 
Overall, it is clear that there is a need to objectively assess the expression stability of 
any candidate reference gene or miRNA before valid conclusions regarding transcript 
regulation can be reached.   
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1.5 Morphological Changes in Neuronal Differentiation 
 
In neuronal cells, molecular events such as gene expression result in dramatic changes 
in cell morphology (the extension of neurites) over the course of differentiation. A 
method of rapidly staining large samples of cells without the need for temperature-
controlled incubation conditions, coupled with a reliable, automated algorithm for 
high-content neurite quantification would potentially allow many more laboratories to 
contribute statistically robust analyses of neurite outgrowth to the body of knowledge. 
Additional work in this area is appended at Appendix F. 
1.6 Objectives of this Study 
As it is important to establish the reliability of biological conclusions drawn from 
gene quantitation, Chapter 2 begins by investigating the reliability of common 
reference genes vis a vis genes selected based on expression stability in a model of 
neuronal differentiation. In order to detect and accurately quantify miRNAs, an 
approach previously used to detect flaviviruses was adapted and validated in Chapter 
3. This validated approach was used to investigate the reliability of reference genes 
used in miRNA studies in Chapter 4. Chapter 5 describes an effort to quantify 
miRNAs directly from cell lysate. A software approach to miRNA assay design is 
described in Chapter 6 to aid in primer design and data organization. This work lays 
part of the foundation for a high-throughput approach to studying the effects of 
miRNAs on mRNAs and vice versa. 
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 : Accurate Quantification of mRNA Chapter 2
Expression Changes in Neuronal Differentiation 
 
2.1 Gene expression in Neuronal Differentiation 
 
Neuronal differentiation occurs over a considerable duration and involves significant 
biochemical and morphological changes. Given the dramatic changes involved, it is 
unwarranted to assume that “housekeeping” genes are invariantly expressed 
throughout neuronal differentiation (Figure 2.1). 
 
 
Figure 2.1 Overview of gene expression during neuronal differentiation. Distinct sets of genes are 
alternately expressed and repressed during neuronal differentiation. Adapted from [3] and [54].  
 
 
In this study we analyzed the expression profiles of 20 candidate reference genes 
shortlisted from microarray expression data of differentiating PC12 cells by RT-
qPCR. We found novel reference genes in genes encoding ribosomal proteins but not 
GAPDH to be reliable reference genes in PC12 neuronal differentiation [95]. 
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2.2 Selection and Analysis of Candidate Reference Gene 
Stability from Microarray Data 
 
We chose to study PC12 cells due to its wide adoption as a model of neuronal 
differentiation. PC12 cells have proven to be an informative model for aspects of 
neuronal differentiation [96, 97]. High-throughput gene expression measurements, in 
particular microarrays have been used to select reference genes. Given the volume of 
publicly available microarray data, it is not surprising that there have been attempts 
made at aggregated meta-analysis of gene stability [89, 98]. The most recent attempts 
at this approach to data mining are even able to account for cell type and experimental 
conditions [98].  Still, differences in lab-specific sample handling and experimental 
variation raise concern over the reliability of such pre-experimental approaches [99]. 
To avoid this, we worked with microarray expression profiles of PC12 cells generated 
wholly in-house, using wild-type PC12 stimulated with NGF and PC12 cells 
expressing GFRα1 and either RET-9 or RET-51 with GDNF.  
 
We analyzed the expression of 21,910 genes by microarray and found 8,568 genes to 
be expressed (p < 0.05) in undifferentiated, NGF-stimulated, and GDNF- stimulated 
PC12 cells in all samples. We next asked how we could arrive at an unbiased analysis 
of the stability of these 8000 genes. As gene expression levels span three orders of 
magnitude or more, a simple heuristic of coefficient of variation (CV) has been put 
forward as a measure of stability [100, 101]. However, CV does not take into account 
sources of variation such as unequal RNA input between samples. Hence, we also 
employed geNorm, a widely used  algorithm that assesses pair-wise variations 
between genes within each sample [102]. The concept underpinning geNorm is that 
two invariant genes would have a constant expression ratio in every sample. While 
this accounts for variances in RNA input, the approach also leaves geNorm open to 
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the selection of tightly co-regulated genes. While this weakness can be mitigated 
through the selection of candidate genes from different functional groups, we decided 
to complement geNorm analysis with an alternative algorithm, Normfinder [103]. 
Normfinder assesses the stability of each individual gene based on its variance 
between samples both within and between user-defined groups. Normfinder is thus 
similar to CV in being vulnerable to sources of technical inter-sample variation. 
However, the use of these two algorithms in tandem provides a robust statistical 
framework with which to analyze gene expression stability.  
 
First we shortlisted the 100 genes with lowest CV as geNorm and Normfinder were 
unable to process expression data on the scale of 8000 genes. Given their common use 
as reference genes, we were surprised when GAPDH and ACTB were not included 
within the top 100 genes.  We then used geNorm and Normfinder to analyze the 
expression stability of these 100 genes including GAPDH and ACTB. Interestingly, 
despite the differences in statistical approaches, both algorithms were in complete 
agreement with regards to the identity of the 20 most stably expressed genes and 
similarly ranked GAPDH and ACTB as the least stable genes.  Examination of the top 
20 ranked genes showed that 13 out of the 20 coded for ribosomal protein genes.  
 
Next, we asked if these 20 genes could serve as reliable reference genes in PC12 cells 





Table 2.1 Stability ranking of microarray expression data from differentiating PC12 cells. ‘Mean’ 
indicates the average relative signal intensity of the gene. GAPDH and ACTB are included for 
reference, but were not ranked as they did not fall within the 100 genes with lowest CV.  
   Rank 
Gene symbol  Definition  Mean  geNorm 
Norm 
-Finder 
RPL29  Ribosomal protein L29  14.04 1 1 
RPL10a  Ribosomal protein L10A 12.49 2 2 
LOC292640  Vps20-associated 1 homolog  10.87 3 3 
LOC498143  Similar to ribosomal protein L15  13.71 4 4 
LOC317275  Similar to ribosomal protein L7-like 1  11.88 7 5 
RPS15  Ribosomal protein S15  12.97 5 6 
ARBP  Acidic ribosomal phosphoprotein P0  14.27 6 7 
RPL14  Ribosomal protein L14  13.89 9 8 
EEF1A1  Eukaryotic translation elongation factor 1 alpha 1  14.17 8 9 
RPS15A  Ribosomal protein S15a  13.93 10 10 
RPL18  Ribosomal protein L18  13.58 11 11 
REPS1 (P)  RalBP1 associated Eps domain containing protein (predicted)  10.73 12 12 
LOC363720  chromatin modifying protein 2B  10.61 14 13 
CNOT8  CCR4-NOT transcription complex, subunit 8  11 15 14 
RTCD1  RNA terminal phosphate cyclase domain 1  10.48 17 15 
RPL19  Ribosomal protein L19  13.74 13 16 
NDUFB6 
(P)  NADH dehydrogenase (ubiquinone) 1 beta subcomplex 6  10.43 16 17 
RPL9  Ribosomal protein L9  13.74 18 18 
LOC499803  Similar to 40S ribosomal protein S3  13.76 19 19 
RPL3  Ribosomal protein L3  14.03 20 20 
ACTB  Actin, beta  13.85 





2.3 Neuronal Differentiation of PC12 Cells 
 
PC12 cells are subjected to a wide variety of differentiation protocols. In addition to 
the canonical neurotrophic factor NGF, we used the depolarizing agent potassium 
chloride (KCl) [104], adenylyl cyclase activator forskolin (Fsk) [105] and ROCK 
inhibitor Y27632 [106] to induce neurite outgrowth and neuronal differentiation in 
PC12 cells. In addition, GDNF was used to induce the neurite outgrowth and 
differentiation of PC12 cells stably expressing GFRα1 and either RET-9 or RET-51. 
We measured the expression of the 20 shortlisted candidate genes along with GAPDH 
and ACTB using RT-qPCR. Neuronal differentiation was induced by all the 
stimulations, as evidenced by outgrowth of neurites (Figure 2.2).  
 
To determine the absolute expression of each gene in every sample, we cloned, 
spectrophotometrically quantified and linearized 300 bp flanking regions of each gene 
to serve as standards. To ensure sample comparability, we analyzed RNA quality 
using a microfluidic gel system (Experion, Biorad) and determined that all RNA 
samples had an RQI of at least 9. The primer sequences, PCR efficiencies, inter- and 
intra-assay variations of each assay were listed in Appendix B. All primers had PCR 






Figure 2.2. Differentiation of PC12 cells. A) Quantification of differentiation as measured by 
proportion of cells bearing at least one neurite of at least one cell body length. B) Representative 
images of control and treated PC12 cells immuno-stained with anti-Neurofilament-200 antibody. 













































2.4 Analysis of Reference Gene Stability from RT-qPCR 
Quantification 
 
Analysis of gene expression using geNorm and Normfinder revealed that the different 
sets of genes were ranked as most stable under each differentiation condition and at 
different time points. The ribosomal protein genes RPL19, RPL29 and RPL3 were 
ranked the most stable genes between NGF-stimulated cells and their controls by both 
geNorm and Normfinder (Figure 2.3). Interestingly, RPL19 and RPL29 were also 
consistently ranked within the five most stable genes whether expression data was 
grouped by stimulation or time point (Figure 2.4). A geNorm pairwise variation 
analysis to determine the least number of genes required revealed that the V2/3 value 
(0.107) of RPL19 and RPL29 excluded the need for a third gene as it was well below 
the V value cutoff of <0.15. A geometric mean of RPL19 and RPL29 was thus 





Figure 2.3 Stability ranking of genes in PC12 cells stimulated with NGF. The ‘Stability Value’ of 
Normfinder and ‘M-Value’ of geNorm are both relative indications of stability. The lower the Stability 
or M-Value, the more stable the gene. 
 
Most Stable Least Stable 
Most Stable Least Stable 
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Figure 2.4 Frequency with which genes were ranked within the top five genes by geNorm and 
Normfinder. There were a total of six groups by treatment and four by time points. RPL19 and RPL29 
were the two most frequently ranked within the top five ranking.  
   
We thus hypothesized that RPL19 and RPL29 may be suitable reference genes for 
PC12 neuronal differentiation in general. At the same time, the poor stability ranking 
of GAPDH and ACTB suggested that normalization to GAPDH or ACTB alone may 
result in a significantly altered gene expression profile. To test this hypothesis, we 
first compared the normalization factors for each sample when normalized to the 
geometric mean of RPL19 and RPL29, the top ranked genes for that differentiation 
stimuli and GAPDH or ACTB alone. The normalization factors (NF) were calculated 
either from the relative expression of GAPDH (NFGAPDH) or ACTB (NFACTB) alone or 
the geometric mean of the expressions of RPL19 and RPL 29 (NFRPL19/RPL29). The 
23 
geometric expression mean of multiple genes has been suggested to be a much more 
robust reference than using a single gene [102, 108].  
2.5 Normalization Factor Deviation from Most Stable Genes 
 
First, we examined the variance between NF based on the two most stable genes in 
each condition (NFtop2) and NFRPL19/RPL29, NFACTB and NFGAPDH. We found that 
NFRPL19/RPL29  varied significantly less than both NFGAPDH and NFACTB in NGF, GDNF 
and KCl stimulated PC12 cells. As RPL19 and RPL29 were the most stable genes in 
Fsk and Y27632 stimulated cells, there was no deviation (Figure 2.5).  
 
Figure 2.5 Comparison of the normalization factors calculated by different reference gene(s). 
Normalization factors (NF) calculated with RPL19/RPL29, ACTB and GAPDH were compared to that 
calculated by the top 2 reference genes recommended by both NormFinder and geNorm, for each 
stimulus.  The percentage deviations were calculated using the following formula: NFRPL19/RPL29; 
NFACTB ; NFGAPDH from NFtop2 (|NFx-NFtop2|/NFtop2) were represented by whisker plots.    
 
The large variance in NF derived from expression of ACTB or GAPDH alone 
suggested that gene expression normalized to ACTB or GAPDH alone might result in 
a very different expression profile as compared to that normalized by RPL19/RPL29 
or the most stable genes for that condition. While the largest variances in NF for both 
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ACTB and GAPDH were to be found in samples exposed to forskolin, we chose to 
examine in detail the impact of NF selection in NGF treated samples as NGF is by far 
the most widely used differentiation agent in PC12 cells. 
 
In NGF-stimulated PC12 cells, we evaluated the effect of using NF from different 
reference genes on the expression profile of EGR-1, ITGA and CRYAB (Figure 2.6). 
The most stable genes under NGF stimulation were RPL29 and RPL10a. We found 
that there was no significant difference between fold changes calculated based on 
NFRPL19/RPL29 and NFRPL29/RPL10A (calculated from RPL29 and RPL10a).  
 
In contrast, normalization based on NFGAPDH resulted in a drastically different 
expression profile from either NFRPL29/19 or NFRPL29/RPL10A. Using a cut-off of 2 fold 
for significant gene regulation, we found that using NFGAPDH would result in the 
interpretation that EGR-1 and ITGA were not significantly upregulated at the 24h and 
72h time points. In contrast, using NFRPL29/19, NFRPL29/RPL10A or NFACTB, EGR-1 and 
ITGA were clearly upregulated at 24h and 72h. We also observed that the 
downregulation of CRYAB at 24h and 72h was exaggerated using NFGAPDH compared 
to NFRPL19/29, NFRPL19/10A and NFACTB. 
Interestingly, Figure 2.6 suggests that ACTB could provide a comparable expression 
profile to NFRPL29/19 and NFRPL29/10A. However, a closer examination of Figure 2.5 
reveals that NF based on ACTB varied at most 40% from NFRPL29/19 and NFRPL29/10A 
under the conditions tested, but much more under other conditions. Hence, we would 
not recommend using ACTB beyond the conditions and time points it has 
demonstrated itself to be comparable to the empirically validated NFs based on 
RPL29/19 and RPL29/10A which were based on a wide range of conditions. 
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Figure 2.6 Interpretation of gene regulation normalized by HKG or validated reference genes in 
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different conclusions of gene regulation. In contrast, a geometric mean of RPL19 and RPL29 or ACTB 
allowed comparable conclusions with the most stable genes RPL29 and RPL10a for A) EGR-1 B) 
ITGA and C) CRYAB regulation. Statistical differences in fold changes were determined by Student’s 
t test, where p < 0.05 was considered significant. (* p < 0.05, ** p < 0.01).  
 
 
The systematic underestimation of upregulated genes and exaggeration of 
downregulated genes indicated possible regulation of GAPDH at these time points. 
Indeed, GAPDH expression normalized by NFACTB, NFRPL19/RPL29 and NFRPL29/RPL10A 
indicated that GAPDH may be upregulated by 2-3 fold between 24h and 72h after 
NGF stimulation. In order to ascertain the existence of such regulation, the 
experiment was repeated with a more intense time-course. The resulting gene profile 
of GAPDH, normalized by NFRPL19/RPL29 confirmed this upregulation. GAPDH was 
indeed upregulated between 24h and 72h, peaking between 26-48h after NGF 
stimulation (Figure 2.7). 
 






This study examined the expression stability of 20 candidate reference genes 
shortlisted from microarray data of PC12 undergoing neuronal differentiation along 
with GAPDH and ACTB, two housekeeping genes commonly used as reference 
genes. We found that GAPDH was significantly regulated during the course of NGF- 
induced neuronal differentiation in PC12 cells and hence cannot be recommended as a 
reference gene. In contrast, RPL29 and RPL19 were ranked as stable by both geNorm 
and Normfinder under a wide range of stimulations and enabled accurate 
normalization of NGF-regulated genes. 
 
Transcript profiling for mRNA benefits from having well-established techniques and 
robustly tested platforms contributing to accurate and reliable results. The field of 
miRNA quantification however is much less mature. miRNA detection and 
quantification poses significant challenges to traditional techniques developed for 
mRNA. The next chapter describes the development of a miRNA detection and 




 : Development of mSMRT-qPCR: High-Chapter 3
Performance SYBR Green I based miRNA 
Quantification 
 
The increasing prominence of small RNAs and in particular miRNAs in biology has 
prompted the development of several methods of miRNA detection and 
quantification. Direct detection methods are based on fluorescent, colorimetric and 
electrical detection. These approaches generally have poor detection limits in the 
range of nanomoles (1014 molecules) to picomoles (1011 molecules), are semi-
quantitiative and have poor discrimination between highly similar sequences [109]. 
Although recent improvements in some fluorescence based methods have claimed 
single-molecule sensitivity [110], indirect methods such as Northern blotting, 
microarrays, RT-qPCR and high-throughput sequencing have established themselves 
as the predominant detection approaches. Unfortunately, Northern blots and 
microarrays require relatively large amounts of samples and also lack specificity for 
mature miRNA as opposed to precursor miRNAs, miRNAs with highly similar 
sequences [111, 112]. Otherwise, the use of specially modified bases (e.g. LNA) 
either in microarray probes or qPCR primers [113] is required to distinguish highly 
similar sequences. Despite having the potential to detect many miRNAs 
simultaneously, the reproducibility of microarrays has been reported to be less 
consistent than RT-qPCR [94, 114]. Furthermore, sequence-specific biases have been 
observed in some sequencing approaches, calling into question their application in 
miRNA quantification [115]. RT-qPCR thus remains the most reliable method and is 
routinely used in the confirmation of results observed in other methods. 
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The most widely used RT-qPCR methods rely on a fluorescent probe to confer 
specificity to assays detecting miRNAs with similar sequences [111]. Due to the short 
length of miRNAs and the continued discovery of many hundreds of novel sequences 
through deep sequencing studies [116, 117], the probe-based approach will eventually 
face practical difficulties in terms of probe design for each novel sequence [118]. 
Although sequence-independent DNA-binding dye approaches have been put 
forward, they generally suffer from poor discrimination between highly similar 
miRNAs [119, 120]. Quantification of miRNAs thus faces the challenges of 
scalability, discrimination between highly similar sequences as well as between 
mature and precursor forms of miRNAs which contain identical sequences. 
We developed a method for highly specific detection of mature miRNAs using a 
modified stem-looped reverse transcription-qPCR (mSMRT-qPCR) [121] based on a 
technology developed for flavivirus detection [122]. This approach was capable of a 
large dynamic range of up to eight logs and had a detection limit of sub-zeptomole 
amounts of miRNA (~10-100 molecules). mSMRT-qPCR was highly selective for 
mature but not precursor forms of miRNAs and was showed specific detection of 
highly similar sequences. Further, the assays could be multiplexed to reduce sample 
requirement with no significant change in assay performances.  
 
3.1 Detection Approach 
 
We noticed that in many miRNA RT-qPCR approaches, the reverse primer was 
completely nested within the reverse transcription oligonucleotide. This allowed only 
the forward qPCR primer to confer assay specificity. Although this strategy allows the 
use of a universal reverse primer, it also limits the specificity achievable by the assay. 
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We hypothesized that by extending the reverse primer we could interrogate the cDNA 
synthesized during reverse transcription through the use of protruding nucleotides and 




Figure 3.1 Schematic of miRNA RT-qPCR strategies. A) A common approach utilizing only the 
reverse transcription oligonucleotide and forward PCR primer to confer assay specificity. (adapted 
from [120]) B) mSMRT-qPCR approach utilizing a stem-looped oligonucleotide at reverse 
transcription and hemi-nested forward and reverse PCR primers interrogate the synthesized cDNA for 
increased assay specificity. 
 
 
3.2 Sensitivity and Selectivity for Mature miRNA 
 
We found that mSMRT-qPCR had a wide dynamic range of up to seven logs and was 
able to detect sub-zeptomole quantities (~100 molecules) of synthetic miRNA and 







Figure 3.2 Dynamic range and sensitivity of mSMRT-qPCR. A) mSMRT-qPCR was able to detect 
102 – 109 molecules of synthetic miR-21 with excellent linearity. B) miR-21 detection curve from 1pg 
to 100ng of total RNA.  
 
 
We also found that the stem-looped oligonucleotide utilized in mSMRT-qPCR was 
able to distinguish the mature form of miRNAs from their precursors well (Table 3.1). 
The additional discrimination afforded by the stem-loop structure appears to be due to 
the an improved RT efficiency of mature but not precursor miRNA. This observation 
has also been made by others using a probe-based approach, and could be due to 
RNA-DNA hybrid stabilization by base stacking [111]. Alternatively, the additional 
double-stranded binding sites afforded by the stem structure could also promote 












Table 3.1 Specificity of mSMRT-qPCR for mature miRNA. 109 molecules of synthetic mature 
miRNAs or in vitro transcribed pre-miRNAs were reverse transcribed with either stem-loop or linear 
RT oligonucleotide and quantified using identical PCR primers. ∆Ct values indicate mSMRT-qPCR 
specificity for mature miRNA. (∆Ct = CtPrecursor – CtMature). 
 
miRNA Assay  Mature (Stem-loop RT)  Mature (Linear RT)  
miRNA Target  Precursor (Ct)  Mature (Ct)  ∆Ct  Precursor (Ct)  Mature (Ct)  ∆Ct  
miR-21  28.0  18.9  9.1  28.5  27.6  0.9  
miR-7-1 30.2  
16.1  
14.1  32.9  
22.5  
10.4  
miR-7-2 26.0  9.9  26.7  4.2  
miR-218-1  28.7  
15.8  
12.9  24.1  
16.6  
7.6  
miR-218-2  25.0  9.2  25.8  9.2  
let-7f-1  21.6  
18.2  
3.4  20.4  
20.8  
-0.4  
let-7f-2  26.8  8.6  26.9  6.1  
let-7g 26.8  18.6  8.2  27.1  21.7  5.4  
let-7i  21.7  18.6  3.1  20.9  20.9  0.0  
 
 
3.3 Assay Specificity and Discrimination  
 
 
An advantage of a probe based approach is the additional layer of specificity granted 
to the assay by the probe sequence in addition to the RT primer and qPCR primers. To 
assess the specificity of our approach between highly similar miRNAs, we designed 
assays specific for the highly similar let-7 family of miRNAs. Interestingly, our 
approach enabled at least 50 fold discrimination between let-7 miRNAs that differed 
by only one nucleotide ( 
Figure 3.3). Interestingly, the performance of mSMRT-qPCR, a SYBR Green I based 
strategy, was at least comparable to a probe-based approach [111]. The inclusion of 
protruding nucleotides appeared to greatly increase the specificity of the assays and 




Figure 3.3 Specificity of mSMRT-qPCR. Assay specificity is expressed in terms of % relative 
detection. A) Sequence alignment of let-7 family miRNA family. B) Specificity of Taqman-based 
assay (from [111]). C) Specificity of mSMRT-qPCR assay. Assay discrimination was in general > 
1000 fold and at least 50 fold (~2% relative detection).  
 
3.4 Application to Complex Biological Samples and 
Multiplexing 
 
We applied mSMRT-qPCR in the examination of miRNAs upregulated by GDNF in 
U251 glioma cells from a panel of miRNAs reported to be dysregulated in gliomas 
[123]. Interestingly we found that GDNF specifically upregulated six miRNAs, 
including miR-218 and miR-7i. As multiplexing would both drastically reduce the 
sample requirement and increase throughput of quantification, we tested mSMRT-
qPCR compatibility with multiplexed reverse transcription.  A multiplex of up to 24 
reverse transcription oligonucleotides resulted in similar interpretations of miRNA 























Figure 3.4 Quantification of GDNF-regulated miRNAs by single-plexed and multiplexed mSMRT-qPCR. U251 total RNA samples were reverse transcribed by single 
miRNA-specific RT oligonucleotide (black lines) or 24-plexed RT oligonucleotides (red lines). Regulation of miRNAs (A) and in particular the let-7 family (B) by GDNF. 





























mSMRT-qPCR was capable of sensitive, specific and accurate detection and 
quantification of miRNA with a detection limit of 10 molecules and starting material 
of 1 pg of total RNA. It was able to discriminate mature from precursor miRNA by at 
least 3 cycles (~10 fold). This discrimination is due to the stem-looped structure of the 
RT primer, possibly by increasing the footprint available for successful reverse 
transcriptase binding. mSMRT-qPCR was also able to distinguish highly similar 
mature miRNA differing by a single nucleotide by at least 50 fold and was achieved 
through the inclusion of a protruding base. This approach thus conferred specificity 
comparable to that achieved using fluorescent probe based approaches. Lastly, we 
tested mSMRT-qPCR in a complex biological sample and found it capable of specific 
reverse transcription of up to 24 miRNAs simultaneously. This multiplexing 
capability allows mSMRT-qPCR scalability to quantify large numbers of miRNA 
from limited samples of RNA.  
 
The development of mSMRT-qPCR allows researchers access to an accurate, reliable 
and scalable approach to miRNA quantification. This frees them from reliance on 
availability of specific assays from commercial sources. However, as in mRNA 
quantification, valid conclusions of miRNA regulation in biological samples require 
reliable internal references. The next chapter describes the evaluation of reference 




 : miRNA Expression Normalization in Chapter 4
Neuronal Differentiation 
 
Establishing reliable profiles of miRNA expression is essential to understanding the 
contributions of miRNAs in neuronal differentiation and other biological processes. It 
has been suggested that because one miRNA may target many transcripts, even small 
changes in miRNA expression could have significant regulatory implications [124, 
125]. This highlights the particular need for an informed choice of reference genes to 
ensure accurate miRNA quantification.  
 
Arbitrarily selected reference genes [61, 126, 127], normalization to the global 
expression mean [108] and selection of the least variant reference gene candidates 
from a pool of ubiquitously expressed genes [124, 128] remain the few options 
available for normalization of miRNA expression. Normalization using mean 
expression is feasible in large-scale studies but in work on a small number of miRNAs 
and/or limited availability of samples global expression data may not be available 
[91]. In many studies of miRNA function [129, 130] or potential clinical applications 
[131, 132], usually only one or two miRNAs are quantified. Such studies highlight the 
need for a reliable pool pre-validated reference genes.  
 
Arbitrarily chosen small RNAs may not always be valid reference genes, in parallel 
with mRNAs chosen for “housekeeping” functions. It is essential that references 
genes for miRNA quantification are determined empirically. Yet it is common to find 
studies relying on a unvalidated reference genes, commonly a small nucleolar RNA 
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such as snoU6 [60, 61, 126, 127, 133] or 5S ribosomal RNA [134, 135] as references 
by virtue of their high expression, ubiquity and traditional use in Northern blots.  
 
To date, there have been limited investigations into validating miRNA reference 
genes for RT-qPCR. Small RNAs or ideally miRNAs should be used as references in 
miRNA quantification to reduce variability due to size bias in isolation [128]. Panels 
of miRNAs have thus far been put forward arbitrarily [128],  based largely on their 
ubiquity, high expression and/or constant expression in physiological tissues [128, 
136] or comparable expression between normal and pathological tissues [87, 124, 
137]. We thus set out to specifically address the stability of genes used as miRNA 
quantification references in neuronal differentiation. Here, the aim was to evaluate the 
suitability of the commonly used small RNAs as reference genes and to establish a 
reliable panel of reference genes for diverse models of neuronal differentiation based 
on RT-qPCR expression measurements.  
  
4.1 Selection of Candidate Reference miRNA and Small 
RNA from Literature 
 
We based our selection of candidate miRNAs from a recent comprehensive RT-
qPCR-based tissue profiling study [136] with the following additional criteria. First, 
candidate miRNAs must be perfectly conserved across human, mouse and rat species 
as these are common sources of models for neuronal differentiation. Second, 
candidate miRNAs must have been unambiguously annotated in miRBase version 16 
[138]. Third, candidate miRNAs should be expressed in neuronal tissues, e.g. brain 
[136]. Fourth, candidate miRNAs must not be clustered in the genome with any other 
candidate miRNA so as to reduce the possibility of co-regulation [81, 139]. We also 
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included miRNAs recommended by a leading commercial miRNA assay supplier 
[140] and stable miRNA candidates from neuroblastoma profiling [108]. The details 
and selection criteria of eight candidate miRNAs and two commonly used small RNA 
controls analyzed in this study were listed in Table 4.1.  
 
It has also been demonstrated that some filter-based methods for RNA isolation may 
lead to variable sample recovery [128, 141, 142]. As such, we eliminated this source 
of variability by the use of partition based method (phenol/chloroform), augmented by 
a non-biological co-precipitant (linear acrylamide) [143, 144]. RNA quality was 
validated using denaturing agarose gel electrophoresis. 
4.2 Induction of Neuronal Differentiation in Cell Models 
 
To assess the stability of the selected genes in diverse paradigms of neuronal 
differentiation, we studied a panel of cells including human ENStem-A neural 
progenitor cells (NPCs), a rat pheochromocytoma cell line (PC12), two 
neuroblastoma cell lines (Neuro-2a [N2A] and SK-N-BE(2)C [BE(2)C]) and the 
neuroblastoma-glioma hybrid cell line NG108-15 (NG108).  Differentiated cells 
displayed neuronal morphology and extensive neurite outgrowth (Figure 4.1) and total 




Table 4.1. List of Candidate Reference miRNAs and Small RNAs 
S/N miRNA Sequence Length (nt) Clustered miRNAs 
(human, based on 
miRbase) 
Reference Comment 





Stable expression in 
neuroblastoma  
2 miR-106b UAAAGUGCUGACAGUGCAGAU 21 miR-93, miR-25 [136] Selected based on 
abundance in brain 
tissue 
3 miR-140-5p CAGUGGUUUUACCCUAUGGUAG 22 NA [136] 
[108] 
Selected based on 
abundance in brain 
tissue 




Selected based on 
abundance in brain 
tissue 





not found in 
miRbase version 16. 
Rno-miR-423* has 
an additional U 
residue at the 3’ end. 
6 miR-26b UUCAAGUAAUUCAGGAUAGGU 22 NA [140] Recommended by 
publication 
7 miR-425 AAUGACACGAUCACUCCCGUUGA 23 miR-191 [108] 
 
Stable expression in 
neuroblastoma 
8 miR-15b UAGCAGCACAUCAUGGUUUACA 22 miR-16-2 [136] 
 
Selected based on 









Used as a single 
reference gene 
10 5S 
(NR_023363)                
Refer to Appendix C 121 >500 instances in 
genome. Multiple 
gene overlaps  





Figure 4.1. Differentiation of neuronal cells. Neuronal differentiation as evidenced by extensive 




Table 4.2.  Induction of Neuronal Differentiation and Total RNA Collection 
Cell 
Model 
Species of Origin Differentiation Agent Time course Reference 
NPC Human Neural Differentiation 
Medium 
0, 3, 7, 10 days [145] 
PC12 Rat NGF (50 ng/ml) 6 h, 24 h, 72 h [146] 
BE(2)C Human RA (10 µM) 6 h, 24 h, 72 h [147, 148] 
N2A Mouse RA (10 µM) 6 h, 24 h, 72 h [17] 
NG108 Mouse-Rat 
Hybrid 










Undifferentiated  Differentiated  
Hoechst 3342       
βIII-tubulin 
Scale bar = 5 um 
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4.3 Evaluation of Candidate Reference Gene Stability in 
Neuronal Differentiation by RT-qPCR 
 
The expression levels of miRNA and small RNA were determined by multiplexed 
RT-qPCR using assays designed as previously described [121]. All the RT-qPCR 
assays showed high efficiency of amplification (~>90%) and low intra- and inter-
assay variations (Appendix C). We noted that the reference gene snoU6b (RNU6-
2/NR_00275, 45 nt) [126, 127, 140] was a truncated version of the snoU6 sequence 
(RNU6-1/NR_004394, 106 nt) and we have used an assay specific for snoU6 to avoid 
ambiguity (the sequences are listed in Appendix D). As seen from Figure 4.2, the 
genes assayed covered a wide range of expression levels. Raw Ct values for each gene 
were log-transformed into relative expression values for stability analysis using 
geNorm and Normfinder.  
 
Figure 4.2. Expression level box plot of Candidate Small RNAs. Box plot representation of 
threshold cycles (Ct) of 5S, snoU6 RNAs, eight candidate miRNAs and three regulated miRNAs (miR-
125b, miR-21 and miR-221) from five cell lines. The Ct is a measure of the relative abundance of the 




Based on the stability analyses, we next investigated if there was a common group of 
genes that could serve as references for all the cell models. As may be expected from 
the diverse models of neuronal differentiation, there was no one gene or group of 
genes that was consistently ranked top in all cell types. This is in agreement with 
previous reports, there was also no correlation between stability ranking and relative 
abundance (as estimated by Ct) [95]. Surprisingly, the highly expressed and 
commonly used 5S and snoU6 small RNAs were consistently ranked as less stable 
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miR26b miR103 miR425 miR106b miR26b miR23a miR140_5p miR140_5p miR26b miR106b miR140_5p 
miR425 miR140_5p miR23a miR140_5p miR425 miR103 miR423 miR26b miR140_5p miR26b 5S 
miR140_5p miR23a miR106b miR15b miR140_5p miR106b miR425 miR425 U6 miR103 miR425 
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As geNorm but not NormFinder was able to make valid comparisons across 
expression measurements from different qPCR runs, we used the geNorm approach to 
determine relative stabilities of the candidate genes across all cell types. Analysis of 
candidate gene expression using geNorm ranked three miRNAs (miR-103, miR-106b 
and miR-26b) as the most stable across all cell types. We noted that miR-26b was 
consistently ranked among the most stable genes in NPC, BE(2)C, N2A and NG108 
cells by geNorm as well as Normfinder. Based on these considerations, we decided to 
evaluate the suitability of miR-103, miR-106b and miR-26b as reference genes for the 
models of neuronal differentiation and have tested the possibility that these three 
genes were comparable to the most stable genes in each model.  
 
Table 4.4. Most stable genes in each cell type.  
Model NF Derived from geNorm Ranking 
geNorm top 
ranked genes 



















































We first calculated the geometric mean of the relative expressions of the top three 
genes ranked by geNorm and NormFinder in each cell line. These values served as 
proxies to estimate the overall deviation in gene expression measurements caused by 
using a gene or set of genes as quantification references [95]. We evaluated the 
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deviation of normalization factors (NF) from the most stable genes in each cell model 
using either the geometric mean of miR-106b, miR-26b and miR-103 (NFoverall), or 
the relative expression of 5S and snoU6 as reference genes for each sample. In cases 
where geNorm and NormFinder rankings differed, comparisons were carried out 
against the top three genes suggested by each approach (Table 4.4). In all cases except 





Figure 4.3. Normalization factor deviations. The deviation of NF derived from either the overall top 
ranked genes (miR-103, miR-106b and miR-26b), or between 5S RNA or snoU6 as single reference 
genes and the top ranked genes by geNorm and Normfinder in each cell model were plotted. In BE(2)C 
cells, geNorm ranked the overall most stable genes as most stable. In NPC cells, Normfinder ranked the 
overall top ranked genes as most stable. In N2A cells, geNorm and Normfinder ranked the same three 




4.4 Impact of Different Reference Genes on Interpretations 
of miRNA Regulation 
 
We next examined the impact of using different normalizers on expression profiles of 
three neuronal miRNAs. miR-125b has been found to promote neuronal 
differentiation and neurite outgrowth [50, 56, 80]. miR-221 is strongly induced by 
NGF in PC12 cells [82] and is also associated with the regulation of cell survival and 
proliferation [149, 150].  miR-21 is a pleiotropic miRNA which has been found to 
contribute to diverse cellular processes including differentiation of various cell types 
[151-153]. The expressions of mir-125b, miR-221 and miR-21 were normalized using 
each of the following NFs: the overall three top ranked miRNAs (NFoverall), the top 
three ranked miRNAs for the model when analyzed by either geNorm or NormFinder 
(NF(geNorm/NormFinder)), 5S (NF5S) or snoU6 RNA (NFU6). The list of genes used in NFs 
derived from multiple genes for each model was listed in Table 4.4.  
 
In BE(2)C cells, relying on snoU6 or 5S RNA reference genes resulted in the 
significant underestimation of miR-125b and miR-21 up-regulation after 72 h of 
treatment with RA as compared to the statistically validated reference genes (p < 0.01 
and p < 0.05 respectively) (Figure 4.4). This observation raised the possibility that the 
expression of snoU6 and 5S may be regulated during the course of differentiation. To 
investigate this further, we performed an independent experiment to verify the 
regulation of 5S and snoU6 RNA, and found significant changes (p < 0.01) in their 
expressions over the course of differentiation (Figure 4.5). These results demonstrated 
the unexpected instability of the commonly used reference genes 5S and snoU6 in 
neuronal differentiation. This finding also highlights that using 5S or snoU6 as single, 
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unverified reference genes in neuronal differentiation could lead to erroneous 
interpretations of gene regulation.  
 
Figure 4.4. Interpretation of miRNA regulation when normalized using different reference genes 
in BE(2)C cells. Fold changes in expressions of (A) miR-125b and (B) miR-21 in BE(2)C cells treated 
with RA compared to control. Relative expressions were normalized to the geometric mean of the 
overall top ranked genes, top three ranked genes by Normfinder or 5S and snoU6 as single reference 
genes. Normalization to 5S RNA alone resulted in the under-estimation of miR-125b and miR-21 
upregulation at 72 h (p < 0.01 and p < 0.05 respectively) as compared to NFOverall or NFNormfinder. No 
significant difference was observed between fold changes calculated by NFOverall and NFNormfinder. In 
BE(2)C cells, geNorm ranked the overall most stable genes as most stable. Significance between fold 
changes was calculated using Student’s t-test and a p value < 0.05 was considered significant. (* p < 




Figure 4.5. 5S and snoU6 RNA are regulated in BE(2)C Cells. 5S and snoU6 RNA expression levels 
were measured over a more detailed time course. The expressions of 5S and snoU6 RNA were 
significantly regulated during the course of differentiation (p < 0.01). Expression levels were 
normalized with NFOverall. Significance between fold changes was calculated using Student’s t-test and 
a p value < 0.05 was considered significant. (* p < 0.05 , ** p < 0.01). 
 
 
Of the overall top ranked genes, only miR-106b was ranked by geNorm and 
NormFinder among the top three most stable genes in PC12 cells. However, 
normalization of miR-125b and miR-221 to NFPC12 geNorm or NFPC12 NormFinder or 
NFoverall did not result in any statistically different fold changes. In contrast, 
normalization with snoU6 resulted in a consistent overestimation of miR-125b and 
miR-221 upregulation at 72 h after NGF treatment (p < 0.01) (Figure 4.6). As 5S 
RNA was included in the calculation of NFPC12 (geNorm/NormFinder), no statistical 
difference was observed in the expression profiles of miR-125b and miR-221.  
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Figure 4.6. Interpretations of miRNA regulation when normalized using different reference genes 
in PC12 cells. Fold changes in expressions of (A) miR-221 and (B) miR-125b in PC12 cells treated 
with NGF compared to control. Relative expressions were normalized to the geometric mean of the 
overall top ranked genes, top three ranked genes by geNorm or Normfinder, or 5S and snoU6 as single 
reference genes. Normalization to snoU6 overestimated miR-221 and miR-125b up-regulation at 72h 
compared to normalization to NFgeNorm, NFNormfinder or NFOverall (p < 0.01). No significant difference was 
observed between the fold change calculated by normalization to NFgeNorm, NFNormfinder or NFOverall. 
Significance between fold changes was calculated using Student’s t-test and a p value < 0.05 was 





Previous studies have proposed the use of the global expression mean [108] or panels 
of miRNAs [87] or small RNAs [128] to normalize miRNA expression 
measurements. These proposals, however, may not be generally applicable when 
different methods are used for sample processing and to the process of neuronal 
differentiation. In this study, ten candidate genes including miRNAs and the 
commonly used references 5S and snoU6 RNAs were evaluated as stable reference 
genes in neuronal differentiation of neural progenitor cells and neuronal cell lines. 
Two independent statistical approaches were applied to evaluate expression stability 
within each cell type and pair-wise analysis was applied across all samples.  
 
The normalization factor (NF) derived from overall top ranked genes across all cell 
lines (miR-106b, miR-26b and miR-103) were compared to the top ranked genes in 
each cell type using two different statistical approaches. In general, the results 
demonstrated a lower variance of the combination of these three miRNAs as 
compared to either 5S or snoU6 RNA. Normalization of the expression of these three 
neuronal miRNAs using the overall top ranked reference genes (miR-103, miR-106b 
and miR-26b) were found to be similar to the use of the top ranked reference genes in 
each cell type and in all cases.  
 
Since neuronal differentiation occurs over an extended period of at least several days, 
it is highly desirable that a chosen reference gene or a panel of genes has a stable 
expression over the period of time. Our data clearly showed that 5S and snoU6 RNAs 
were regulated over the time course of neuronal differentiation and using either 5S or 
snoU6 RNA as single reference genes resulted in aberrant expression profiles. This 
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raises valid concerns of using them as reference genes in this and possibly other 
processes that occur over extended periods of time. 
 
It is critical to evaluate the normalization strategies routinely employed with the 
intention of minimizing technical variation. In particular, the selection of reference 
genes has a large impact on the expression profiles obtained whether in miRNA, 
mRNA or protein expression studies. Stable, statistically verified references are 
crucial to building reliable expression profiles. We have shown here that 5S RNA and 
snoU6, two commonly used reference genes, are stable in some but not all instances 
and are therefore unreliable normalizers for miRNA expression in neuronal 
differentiation. In addition, we have identified a panel of miRNAs (miR-106b, miR-
26b and miR-103) that can serve as reliable reference miRNAs for neuronal 
differentiation.  
 
An important source of variation arises from preanalytical procedures such as sample 
handling and RNA preparation. In particular, a method that eliminates the need for 
RNA purification from crude cell lysates would in principle simultaneously reduce 




 : Development of a Direct RT-qPCR Chapter 5
Approach without RNA Isolation for Simultaneous 
Quantification of miRNA and mRNA 
 
 
Accurate and sensitive quantification of miRNA expression necessitates an approach 
that surpasses semi-quantitative Northern blotting in sensitivity and resolution. As 
previously described, RT-qPCR thus remains the most reliable, sensitive and scalable 
technology for miRNA quantification. Regardless of the detection platform, nearly all 
methods require pure RNA from experimental samples as input for reliable results. At 
the same time, intensive sequencing has resulted in accelerated discovery of many 
more novel miRNAs with as yet unexplored functions. In this context, an approach 
that allows assay customization, multiplexed detection of both annotated and novel 
miRNAs with minimum sample processing is highly desirable. 
 
Here, we describe a modification of the mSMRT-qPCR miRNA quantification 
approach that is compatible with efficient lysis, DNase treatment and direct, 
multiplexed reverse transcription of cultured cells, using a reaction buffer containing 
off-the-shelf surfactants that are commonly used in cell lysis [121].  Using this 
protocol, we have demonstrated that the expressions of both annotated (miRBase 
release 15) and novel miRNAs can be rapidly and reliably quantified from 10 to 
10,000 cells and 10 different cell lines without the need for RNA isolation [154]. This 
cost-effective, robust and reliable protocol for multiplexed detection of miRNAs 




5.1 Workflow and Performance 
 
 
Figure 5.1. Workflow for direct miRNA quantification from cell lysates. The flowchart depicts the 
streamlined workflow which dispenses with time and labor intensive RNA isolation procedures.  
 
The experimental design features a simple workflow to prepare cDNA from cell 
lysates using multiplexed stem-looped mediated reverse transcription and perform 
SYBR Green I based qPCR to quantify miRNAs from multiple samples (Figure 5.1). 
This method is well-suited to processing cell line samples which can be grown in a 
standard 96-well format. Detection of miRNAs from as few as 10 cells to as confluent 
conditions as 10,000 cells per well in 96-well plate was efficient either with or 
without RNA isolation prior to mSMRT-qPCR (Figure 5.2). It is important to note 




We next applied the protocol to 10 different human cell lines and observed reliable 
quantification of miRNAs without RNA isolation (Figure 5.3). While we have shown 
that RNase inhibitors did not enhance detection of miRNAs both here and elsewhere 


















Isolated, R2 = 0.997
Direct (+DNase), R2 = 0.996
Direct (-DNase)
Figure 5.2 Detection curve of miR-21. hsa-miR-21 detection curve from 10 to 10,000 U251 cells 
per 96-well plate well. Cells lysate was directly reverse transcribed () or treated with DNase before 
reverse transcription (♦). DNase treatment was necessary to enable detection of miR21 comparable to 
RNA isolation at 10,000 cells. Detection of hsa-miR-21 from total RNA isolated from 10 to 10,000 
cells was carried out and served as controls (). 
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Figure 5.3 Detection of miRNAs from 10 cell lines. cDNA from 10,000 cells derived from either 
direct RT in lysis buffer (solid bars) or RNA isolation (open bars) from10,000 cells showed 
comparable Ct values. miR-134 was detectable in cells directly lysed in RT buffer but not from RNA 




Using this approach, novel miRNAs such as hsa-miR-4286 and hsa-miR-4323, for 
which there are yet to be available commercial assays, were successfully detected. 
This demonstrates the ease of customization and potential for detection of any 
miRNA rapidly and reliably. Similarly, the simplicity and efficiency of this approach 
is demonstrated through its comparable results with laborious RNA isolation 
dependent methods in 10 different cell lines.  
 
5.2 Adaptation of a qPCR buffer for reverse transcription of 
miRNA and total RNA  
 
 
In the course of this work, it became attractive to look for an alternative to the 
proprietary buffer provided by the commercial supplier for the MMLV reverse 
transcription (RT) enzyme used in our studies. In theory, RT can be thought of as 
primarily a RNA-dependent DNA polymerase. However, RT buffers contain 
components often incompatible with downstream PCR reactions. For example, 
dithiothreitol (DTT) is a common additive in RT reaction buffers that is used as a 
reducing agent. However, concentrations of DTT used in RT inhibit the activity of 
many DNA-dependent DNA polymerases in PCR reactions [155] and furthermore 
interferes with fluorescence-based detection [156]. Hence a DNA polymerase reaction 
buffer may serve as a reasonable and indeed desirable base from which to find an 
alternative RT buffer. Xtensa-SG (Xtensa) is a qPCR reaction buffer that is 
proprietary and readily available in our laboratory. It was proven to exhibit 
exceptional performance in terms of supporting DNA polymerase activity in qPCR 
and is routinely used in our work. As such, it was used as a base formulation for a 
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novel RT buffer. Presented here are preliminary results of investigations in this 
direction. 
 
Xtensa contained 200 µM dNTP while the MMLV enzyme supplier called for 500 
µM dNTP. Thus, 3x Xtensa was first compared to the proprietary buffer. It was 
observed that using 3x Xtensa for reverse transcription was inferior to the proprietary 
buffer even though both cDNA products were amplified with 1x Xtensa in qPCR. 
This led to the hypothesis that there were components in Xtensa which were 
inhibitory at 3x concentration. Noting that 1x Xtensa performed robustly in a wide 
variety of assays and conditions, we hypothesized that the reverse transcription 
reaction would not be compromised in 1x Xtensa, but supplemented with 300 µM 
dNTP.   
 
Serial dilutions of synthetic miRNA (let7d) or total RNA were reverse transcribed 
using either specific mSMRT primers, multiplexed mSMRT primers or random 
hexamers. The RT products were diluted 10% v/v and 5 uL of the diluted product was 
used as template for 25 µl qPCR reactions.  
 
Let7d synthetic RNA was efficiently reverse transcribed by a 2x concentration of RT 
enzyme in both Xtensa-SG and Improm-II buffer. These promising results prompted 
the next set of experiments, where Xtensa-SG buffer were proved comparable even 
with 1x RT enzyme concentration to the commercial formulation (Figure 5.4). This 
promising performance prompted us to further explore the capabilities of Xtensa in 





Figure 5.4. Detection of let-7d using Xtensa-RT. Xtensa RT buffer performed comparably to the 
commercial MMLV buffer. A) Xtensa allowed linear detection over four logs with comparable 
linearity to the commercial MMLV buffer (R2 > 0.99) when 2x enzyme concentration was used under 
both conditions. B) Real-time detection curve for let-7d with 2x enzyme concentration using Xtensa 
(blue) and commercial buffer (red). C) At 1x enzyme concentration, Xtensa was still able to provide 
linear detection comparable to the commercial buffer. 
 
  








Let-7d Detection Curve  
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To test the ability of Xtensa as an RT buffer for mRNA transcripts, we reverse 
transcribed total RNA using random primers in either the modified Xtensa or MMLV 
buffer. Interestingly, modified Xtensa allowed excellent linear detection of GAPDH 
mRNA (R2 > 0.999) from 10 pg to 10 ng of total RNA from LN229 cells and was 
comparable to the commercial MMLV buffer (Figure 5.5). 
 
 
Figure 5.5. Detection of an mRNA transcript from total LN229 RNA using Xtensa RT buffer. A) 
Xtensa performed comparably with the commercial MMLV buffer and allowed linear detection of 
GAPDH transcript from total RNA using random hexamers as RT primers. B) Detection curve of 
GAPDH using Xtensa  (blue) and the commercial MMLV (red) buffers allowed detection of GAPDH 






Lg ng total RNA 
10 ng  
GAPDH 
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5.3 Adaptation of mSMRT –qPCR for detection of miRNA 
and mRNA from a single reverse transcription reaction 
The ability to reverse-transcribe both miRNA and their mRNA targets from a single 
RNA stample simultaneously would greatly streamline studies of miRNA-mRNA 
interactions. Thus, we next asked if mSMRT could be used in conjunction with 
commonly reverse transcription primers such as oligo dT (dT15) or random primers 
(N6). The following describes preliminary data in this direction. We reverse 
transcribed total RNA using either dT15 or N6 in the presence or absence of 
multiplexed mSMRT primers, then quantified GAPDH or miR-21 to determine if the 
presence of mSMRT primers affected mRNA detection; or if the presence of dT15 or 
N6 affected miRNA detection.  
 
Gratifyingly, the presence of mSMRT primers did not adversely affect the detection 
of GAPDH mRNA. Unexpectedly, the presence of mSMRT primers alone was able to 
mediate reverse transcription of GAPDH mRNA, albeit significantly less efficiently 
(Figure 5.6). Conversely, we found that the presence of either dT15 or random 
primers did not adversely affect detection of miR-21. Interestingly, random primers 
(but not dT15) were able to mediate reverse transcription miR-21 and gave rise to a 
very late, but detectable signal (Ct =37.3, Ct = ~ 6.6 compared to mSMRT alone) 
(Figure 5.6). It is possible that the some miR-21 transcripts were randomly primed, 
but were very inefficiently amplified during qPCR as they lacked the additional 
sequences in the stem-loop section of the mSMRT primer to allow binding of the 





Figure 5.6. Effect of mSMRT on mRNA detection and dT15 and N6 on miRNA detection. 100 ng 
of total RNA from PC12 cells was reverse transcribed in the presence of mSMRT primers only, 
mSMRT and dT15 (S+T15), mSMRT and random primers (S+N6), dT15 (T15) only or random 
primers only (N6). A) The presence of mSMRT did not adversely affect detection of GAPDH. In fact 
mSMRT primers alone were sufficient to reverse transcribe GAPDH mRNA. No signal was detected in 
NTC wells. B) miR-21 detection was not adversely affected by presence of either dT15 or random 
primers. Random primers but not dT15 was sufficient to mediate detection of miR-21, but with very 








The chapter described a novel adaptation of mSMRT-qPCR to allow an integrated 
workflow for detection of miRNA from cells without the need for RNA isolation. 
This method provided comparable results with the RNA isolation using the phase-
separation approach in a wide range of cell lines. This chapter also describes the 
adaptation of a PCR buffer for use in MMLV mediated reverse transcription as an 
alternative to the commercial buffer supplied. Lastly, it described preliminary results 
in the direction of developing an approach based on mSMRT-qPCR for simultaneous 
reverse transcription of miRNA and mRNA from a single sample.  
 
Even with an efficient downstream process, the manual design of specific quantitative 
assays remains a potentially time- and resource-consuming endeavor. Studies with the 
aim of quantifying more than a few miRNAs require a more efficient, and if possible 
automated, workflow providing accurate primer designs in line with the specifications 
of the quantification approach. The next chapter describes an in-house, Excel based 
software approach to automate aspects of mSMRT-qPCR assay design.  
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 : Development of A Software Approach to Chapter 6
mSMRT-qPCR Primer Design 
 
The design of large numbers of mSMRT-qPCR assay designs necessitates an efficient 
method of in silico sequence manipulation and validation. In particular, steps taken to 
optimize an assay often require laborious manual inspection and correction for 
sequences that may cause undesired hybridization events. For example, a change 
made in the 3’ stem region of an RT primer to minimize primer-primer interaction at 
the PCR step also requires a concordant change in its 5’ internal complement stem 
sequence. Such modifications are common and essential for optimal designs to 
maximize assay specificity and minimize side-reactions and hybridization 
inefficiencies.  
 
In order to facilitate efficient modification and retrieval of assay designs, we have 
developed a system, mSMRT-Assistant (SMRTA) to allow semi-automated sequence 
manipulation. SMRTA is a tool developed on the Microsoft Excel platform that 
allows for accelerated designs of mSMRT-qPCR assays based on essential design 
parameters. The algorithms accelerate design changes by automatically accounting for 
upstream design changes in subsequent design steps. For example, a single-base 
change in the RT primer will be automatically accounted for in the design of the 
qPCR reverse primer without user intervention. The user is thus freed from tedious 
base-counting and assay designs are thus protected from potential human error. The 
use of the ubiquitous Excel platform enables even new team members to design 
efficient, specific mSMRT-qPCR assays with ease.  
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6.1 Design Principle and Interface  
 
SMRTA was developed using Excel 2003 and will work on Excel 2003 and later. It 
has been tested on Excel 2007 and Excel 2010. Excel afforded the application of 
simple algorithms for sequence manipulation (e.g. changing U to A, finding the 
reverse complement) and was readily available.  




Figure 6.1. mSMRT Design Parameters. SMRTA defines the reverse transcription primers in 
discrete sections from 5’ to 3’. A) The brown region represents the sequence synthesized by reverse 
transcriptase. B) At qPCR temperatures (60 oC) Prt linearizes. The PCR gap is the number of 
nucleotides between the forward and reverse PCR primers. C) An example of qPCR primers using 






Designing a set of primers for a miRNA begins with input of the miRNA sequence of 
interest. Batches of primers can be designed for multiple miRNAs by pasting the 
respective sequences in multiple rows (Figure 6.2).  
 
 
Figure 6.2. SMRTA interface. The sequence manipulations are presented in a stepwise manner to 
allow user intervention at every design decision. The columns with a light blue header indicate that 
user input is needed.  
 
6.2 Designing the Reverse Transcription Primer (Prt) 
 
The design process begins with retrieval of mature miRNA sequences from miRBase. 
This can be done ad hoc for single miRNAs or systematically by first downloading 
the database from miRBase. The latest version of the database is available as a 
compressed file archive at ftp://mirbase.org/pub/mirbase/CURRENT/mature.fa.gz 
(June 2011). Once extracted, the archive will yield all the mature miRNAs sequences 
in the current version of miRBase in FASTA format. Excel does not natively support 
FASTA, but the file can easily be converted using online tools such as 
http://darwin.biochem.okstate.edu/fasta2tab/ which allows the data to be easily 
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imported into Excel in a tab-delimited format (Figure 6.3). Once in Excel, color 
coding and sorting are easily applied to obtain a customized database. Importantly, 
this allows multiple or even all known miRNAs for an organism of interest to be 
easily imported into SMRTA for batch primer designing.  The design of mSMRT-
qPCR primers for hsa-miR-106b will be used to illustrate SMRTA function. 
 
Figure 6.3. miRBase data conversion process. A) FASTA format directly downloaded from 
miRBase. B) Tab delimited format converted by tool at http://darwin.biochem.okstate.edu/fasta2tab. C) 








Figure 6.4 SMRTA sequence analysis. Simple features such as the putative seed sequence 
(nucleotides 2-7) of a miRNA can be analyzed and used to sort imported sequences. 
 
 
The imported sequences can be analyzed for features such as the seed sequence 
(Figure 6.4) using Excel’s native sequence manipulation commands. (Refer to 
Appendix E for list of Excel formulae and Visual Basic code used in SMRTA). The 
first user design decision is the number nucleotides to target at the 3’ end of the 
miRNA using the stem-looped reverse transcription primer (Prt). A short miRNA 
targeting sequence would result in unfavorable hybridization kinetics at reverse 
transcription; while a sequence that is longer may result in more efficient reverse 
transcription but would also result in fewer nucleotides available for forward qPCR 
primer (Pf) binding leading to inefficient amplification and a compromised detection 
limit depending on the 5’ GC content of the miRNA (Figure 6.5).  
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Figure 6.5. Implications of miRNA targeting sequence length. A) SMRTA interface for RT primer 
design. B) A longer miRNA targeting sequence allows increased RT primer-miRNA binding and 
potentially more efficient RT. However, this results in a shorter sequence for forward qPCR primer (Pf) 
binding. C) The effect of reduced Pf binding may be more pronounced in 5’ AU rich miRNAs such as 
hsa-miR-938 than in 5’ GC rich miRNAs such as hsa-miR-423-5p.  
 
As a general rule, we recommend a miRNA targeting sequence of not more than eight 
nucleotides and not less than five nucleotides. This allows, with a protrusion of one 
nucleotide on the reverse qPCR primer (Pr), a minimum length of nine nucleotides for 
hsa-miR-938 UGCCCUUAAAGGUGAACCCAGU 





Pf binding during the initial cycles of qPCR (miRNA). Alternatively, the qPCR 
annealing temperature could be reduced during the initial cycles to accommodate the 
low Tm of the Pf before the amplicons incorporate the Tm tag. The stem and loop 
sequences can be customized. Any change in the 3’ stem sequence or loop will be 
accounted for in the sequence of Prt and Pr in the subsequent design steps. In general, 
any stem with five or six nucleotides and GC content > 50% should allow the stem-
loop structure to be favored at RT but not qPCR conditions as required by the 
mSMRT-qPCR approach. The ‘RT dG’ and ‘PCR dG’ fields are thus meant for 
archival purposes to document the free energies of the final Prt design. The free 
energy of possible secondary structures can be calculated using the free online tool 
mfold (http://mfold.rna.albany.edu/?q=mfold/DNA-Folding-Form).  As the Prt 
sequence may be altered in subsequent design steps, it is not recommended to access 
mfold at this point.
 
6.3 Designing the qPCR Primers (Pf and Pr) 
 
Once a preliminary Prt design is reached, the qPCR primers Pf and Pr can be 
designed. The principal considerations for Pf and Pr are Tm, primer-primer 
interaction and target specificity. The Tm of the Pf is determined by its Pf overlap and 
5’ Tm tag sequence. In general, a GC rich tag (up to 100% GC) is needed to raise the 
Tm above 55 oC to reduce spurious primer annealing. An Excel conditional formatting 
command can be applied to indicate an acceptable Tm (e.g.  55 ≤ Tm ≤ 64, 
determined empirically). We used an algorithm based on the nearest neighbor 
modified in-house by Zhou Kang to incorporate effect of mono- and bivalent salts 
according to [157].  
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Figure 6.6. Pf and Pr design interface.  
 
The principal considerations of Pr design lie in the number of nucleotides Pr should protrude 
from Prt. This is especially important when discriminating between highly similar sequences (e.g. 
miRNA family members as in  
Figure 3.3). The Tm of Pr can be easily increased by increasing the number of 
nucleotides Pr overlaps with Prt. If an exceptionally small loop sequence is used, the 
user should be aware that the 5’ end of the stem is GC rich and more importantly 
perfectly complementary to the 3’ end. However, as the 3’ stem of Prt is equally GC-
rich and able to sufficiently increase Tm over a short length, this is a relatively minor 
consideration.  
 
The critical consideration at this stage is to minimize primer-primer interactions. To 
this end, we have found the Oligo Analysis tool in the free online version of Beacon 
Designer ® useful (http://www.premierbiosoft.com/qOligo/Sequence.jsp?PID=1). 
The considerations for primer design have been well elaborated elsewhere [158] and 
are similar for SMRTA, with the exception that the amplicon length is restricted 
largely due to the small size of miRNA. The difference in predicted Tm is 
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automatically calculated and the user is warned by Excel’s conditional formatting if 
the difference is larger than 2 oC.  The ‘PCR Gap (Overlap Check)’ is provided as 
primer-dimers arising from Pf-Pr overlaps may compromise assay qPCR performance 
(a ‘0’ indicates that Pf and Pr primers are head-to-head but do not overlap).  
 
The user will frequently find that in order to minimize self- or cross-primer 
interactions, one or more primers (including Prt, since it impacts the 5’ end of Pr) 
need to be altered. This can be a frustrating, iterative manual proces. SMRTA 
streamlines this workflow by automatically updating Prt, Pf and Pr to accommodate 
such design changes. For example, a change in Prt at the 3’ end of the stem would 
result in the 5’ end being modified to preserve perfect stem complementarity and 
simultaneously updating the Pr sequence, Tm and Pf-Pr Tm difference. In practice, 
several iterations are common before an optimized design is reached. SMRTA thus 
also serves as a design log to allow systematic optimization of an assay. Once a 
design is finalized, the free energy of the secondary structure can be determined using 
mfold to confirm its stem-loop structure during reverse transcription and linearization 
during qPCR. 
 
Figure 6.7. mSMRT archival function.  
 
Finally, the Excel format allows SMRTA can be used as an archive for primer designs 
(Figure 6.7). The expected qPCR amplicon sequence and length can be easily 





Designing large numbers of primers can be laborious and time-consuming, especially 
in approaches requiring customized sequence manipulations (e.g. stem-loop forming, 
Tm calculation based on inclusion of Tm tags). SMRTA was developed to streamline 
the workflow for designing mSMRT-qPCR primers. SMRTA automates mundane 
sequence manipulation tasks and additionally provides an avenue for systematically 
archiving assay design and performances. Further improvements to this approach such 
as free energy calculation and database-wide checks for promiscuous hybridization 
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7.1 Conclusion  
 
Accurate quantification of miRNA and mRNA transcripts is the cornerstone of 
understanding the role of miRNA in the many cellular processes they have been 
implicated in. This work has addressed critical aspects underlying quantitative studies 
through the examination of the choice of both mRNA and miRNA reference genes in 
neuronal differentiation. We have also developed a high-performance RT-qPCR based 
approach that can be applied in single or multiplex to accurately profile miRNA 
expression and begun expanding on its capabilities toward an integrated transcript 
quantification approach.  
 
7.2 Direct quantification of mRNA and miRNA from Cell 
Lysates 
 
An obvious extension of the work described in 0 is the development of an approach 
that integrates mRNA detection with miRNA detection directly from cell lysates. This 
may present particular challenges as mRNAs are much longer and thus prone to 
degradation [84] compared to miRNA [141]. A possible solution may be to add 
RNase inhibitors to the solution. However, the DNase denaturation may compromise 
RNase activity and result in RNA degradation. Despite the challenges, the prospect of 
directly quantifying both mRNA and miRNA simultaneously is an extremely 
attractive prospect as it greatly improves throughput and meaningful biological 
interpretation of the results. Commercial kits are increasingly available, but given the 
results we have obtained and as described in 0, this appears to be an eminently 
feasible direction that has the potential to save much resource through the use of 
commonly available reagents.  
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7.3 Intronic miRNAs and mRNA Splicing 
  
The expression of spliced isoform receptors and the maturation of miRNAs share the 
characteristic of being examples of stimuli-sensitive, sequence-specific RNA 
processing. Examples of miRNAs contributing to a feed-forward mechanism of its 
host gene’s actions [73, 159], including altering a target gene’s stability through 
alternate splicing [65] (Figure 7.1).  
 
 
Figure 7.1 Intronic miRNAs. Introns may carry miRNAs, which may act in either a feed-forward or 
feedback loop to regulate its host gene. [73, 160] 
 
Alternatively spliced receptors engender distinct cellular outcomes which are 
mediated by miRNAs [148]. It is likely that in vivo splicing events are driven 
indirectly by miRNA action on expression of splicing regulators or even direct 
modulation through sequence specific targeting of spliceosome activity [65]. It 
remains to be seen if either an intra-genic or nearby, co-transcribed miRNA 
influences expression patterns of specific isoforms. Using the approaches described 
herein, it is possible to accurately determine if the abundance of a particular isoform 
of a gene transcript is correlated with the expression of a miRNA or set of miRNAs. 
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Cell Culture and Treatments 
SKN-BE(2)C, Neuro, Neuro-2A (N2A) and NG-108 were cultured in DMEM (Sigma 
1152) supplemented with 10% fetal bovine serum (FBS, Sigma, MO, USA). PC12 
cells were cultured with DMEM supplemented with 10% FBS and 5% horse serum 
(HS). ENStem-A neural precursor (NPC) cells were cultured in neural expansion 
medium (Millipore, MA, USA). For differentiation, BE(2)C, N2A and NG-108 cells 
were incubated overnight in 0.5% FBS. BE(2)C and N2A cells were treated with 
10µM retinoic acid (Sigma). NG-108 cells were treated with 50ng/ml GDNF 
(Peprotech, NJ, USA). PC12 cells were incubated overnight with 0.5% FBS / 0.25% 
HS and then treated with 50ng/ml NGF (Preprotec). NPC cells were cultured in 
Neural Differentiation Medium (Millipore) to induce differentiation.  
 
Immunocytochemistry 
Control and treated cells were fixed in 4% paraformaldehyde in PBS for 15 min at 37 
oC, followed by ice-cold methanol at -20 oC for 15 min. Cells were washed twice with 
1 x PBS and blocked with normal goat serum (1:10 dilution in 0.5% Triton X-
100/PBS, Dako, Glostrup, Denmark) for 30 min at 37 oC. The cells were then 
incubated with βIII tubulin antibody (Tuj-1, MAB1195, R&D Systems) at 1:50 
dilution in 0.1% Triton X-100/ 0.1% BSA/ 1 x PBS for 1 h at 37 oC. Cells were then 
washed three times in PBS. Cells were then incubated with goat anti-mouse Alexa 
Fluor 546 secondary antibody (Molecular Probes, Life Technologies, CA, USA) 
diluted at 1:200. Nuclei were stained with 1 µg/mL Hoescht 3342 (Sigma). Images 
were captured using a fluorescence-equipped Zeiss Axio Observer Z1 Inverted 
Microscope (Carl Zeiss, Germany). 
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RNA Isolation and Reverse transcription and Quantitative PCR for mRNA  
Total RNA from PC12 cells was prepared using TRIzol reagent (Invitrogen, CA) 
according to manufacturer’s instruction. Total RNA was collected from samples in 
quadruplicate at each treatment time point and the integrity of the RNA validated by 
denaturing agarose gel electrophoresis and using the StdSens analysis chip on the 
Experion Automated Electrophoresis System (BioRad, CA). The Experion Automated 
Electrophoresis System assigns a RQI to each RNA electropherogram which ranges 
from 10 (intact RNA) to 1 (completely degraded RNA). RNA concentration was 
quantified using a NanoDrop ND-1000 spectrophotometer (Thermo Scientific, 
Wilmington, DE), and the 260/280 and 260/230 ratios were examined for protein and 
solvent contamination.  5 µg of total RNA were reverse transcribed in a total volume 
of 20 µl containing 400 U of ImpromII and 0.5 µg of random hexamer (Promega, 
Madison, WI) for 60 min at 42°C according to the manufacturer’s instructions. The 
reaction was terminated by heating at 70°C for 5 min, and the cDNA was diluted 1:20 
for quantitative real-time PCR.  
 
Real-time PCR was performed on Biorad iCycler 4 Real-Time PCR Detection System 
(Bio-Rad, Hercules, CA) using SYBR Green I. The threshold cycles (Ct) were 
calculated using the iQ5 Optical system software version 2.0. Real-time PCR was 
performed after an initial denaturation for 10 min at 95°C, followed by 40 cycles of 
30s denaturation at 95°C, 30s annealing at 60°C, and 30s extension at 72°C. 
Fluorescent detection was performed at the annealing phase. Melt curve analysis was 
carried out at the end of the cycling to confirm that a single product had been 
amplified. Primer dimer formation in all the assays showed distinct melt 
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characteristics from the correct amplicons. The reaction was performed in a total 
volume of 40 µl in 1x XtensaMix-SG (BioWORKS, Singapore), containing 2.5 mM 
MgCl2, 10 pmol of each primer, and 0.5 U of KlearTaq Hotstart DNA polymerase 
(KBioscience,UK). All real-time PCR quantification was performed simultaneously 
with linearized plasmid standards and a non-template control [161] 
 
Primer Design and Plasmid Standards  
The Genbank accession for each candidate reference gene was retrieved from the 
Illumina microarray probe set and compared to the NCBI RefSeq database (Release 
16; http://www.ncbi.nlm.nih.gov). Transcript splicing sites were retrieved from 
Ensembl (http://www.ensembl.org). Where more than one transcript matched the 
probe, the sequences were aligned and the primers were designed to amplify the 
consensus region. Vector NTI Advance 10 was used to design two sets of primers for 
each target gene. The first set of primers generates an amplicon of ~300 bp and is 
used as a template for RT-qPCR of the targeted gene. The template was subcloned 
into pGEMT-easy (Promega) vector as previously described [54][55]. The second set 
of primers was used for RT-qPCR and was designed to amplify a ~100bp region 
within the ~300bp template. Both primer sets were exon spanning to avoid 
amplification from genomic sequences. Where possible, primers for RT-qPCR were 
designed to target the same exons used in the Illumina Expression BeadChip.  All 
primer sequences were evaluated for possible false priming to known rat sequences 
using the NCBI BLAST tool (http://blast.ncbi.nlm.nih.gov/). All products generated 




RNA Isolation and Reverse transcription and Quantitative PCR for miRNA 
Cells were lysed in Tri-Reagent (Sigma) with the following modifications to 
manufacturer’s instructions. Following chloroform extraction, the aqueous phase of 
each sample was added to 20 µg of linear acrylamide (Ambion, TX, USA). Total 
RNA was precipitated by adding three volumes of ethanol to the aqueous phase. The 
resulting pellet was washed twice in 70 % ethanol and resuspended in 30 µl of 
diethylpyrocarbonate-treated water. 0.5 µg of total RNA was assayed by denaturing 
agarose gel electrophoresis to determine RNA quality and presence of small RNA 
fraction. Sample purity from proteins and phenol contaminants and RNA 
concentration were determined spectrophotometrically using a Nanodrop 2000 
(Thermo-Fisher Scientific, MA, USA).  
400 ng of total RNA was reverse transcribed using ImProm-II reverse transcriptase 
(Promega, WI, USA) in the presence of 2.5 mM MgCl2, 1 mM dNTPs (Bioline, 
London, UK) and 1 µM of multiplexed reverse transcription primers. Stem-looped 
reverse transcription oligonucleotide primers were synthesized by Sigma. The thermal 
cycling parameters for reverse transcription were as follows: 30 min at 42 oC for 
reverse transcription followed by 10 min at 70oC for enzyme deactivation. The cDNA 
was diluted 1:20 times for qPCR.   
 
Each gene was assayed on plates containing duplicate wells of cDNA from all 
samples of each model of neuronal differentiation. Each 25 uL reaction contained the 
following: 2.5 mM MgCl2, 1x XtensaMix-SG (BioWORKS, Singapore), 20 pmol of 
each primer and 1U of Kleartaq Hotstart DNA polymerase (KBiosciences, London, 
UK). All qPCR reactions were carried out on Biorad CFX-96 machines (Biorad, CA, 
USA) using SYBR Green I detection. The thermal cycling parameters used were as 
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follows. A 10 min initial denaturation at 95 oC, one cycle of 60 oC for 5min, followed 
by 50 cycles of 2 step amplification 95 oC for 10 s and 60 oC for 30 s. The Biorad 
CFX manager v1.6 was used to execute the thermal cycling parameters on the CFX-
96 machines, collect and process the real-time fluorescence data using automatic Ct 
determination. All data files were then inspected to ensure correct baseline correction 
and Ct determination. Raw Ct values for each gene were log-transformed into relative 
expression values by the following formula 2 Ct(min)-Ct(sample) where Ctmin was the lowest 
Ct detected among all the samples for that gene within each qPCR plate. Variation 
between duplicate wells was less than 0.5 cycles.  
 
Reverse Transcription and Quantitative PCR of miRNA without RNA Isolation 
Culture media was aspirated and cells washed gently with PBS. Cells were lysed in a 
buffer containing the following : 1.25x Improm-II reverse transcriptase buffer 
(Promega), 2% Triton X-100 (Biorad), 2% Nonidet P40 (Roche, IN, USA),  625 µM 
dNTP (Bioline), 1.5 mM MgCl2, 2 units RQ1 Rnase-free DNase (Promega). The 
lysate was incubated for 37 oC for 30 min, followed by 70 oC for 10 min for DNase 
inactivation. 100 nM mSMRT primers and 1 µl Improm-II reverse transcriptase (per 
50 µl reaction) was added to the lysate (Promega) and incubated at 42 oC for 30 min, 
followed by 70 oC for 5 min to inactivate the RT enzyme. The cDNA was diluted 1:10 
for qPCR, which was carried out as described above. 
 
Adaptation of a qPCR buffer for reverse transcription of miRNA and total RNA 
Serial dilutions of synthetic let-7d miRNA (Sigma) or total RNA from LN229 cells 
were reverse transcribed using Improm-II (Promega) in the presence of 2.5 mM 
MgCl2, 1x Xtensa (BioWorks), additional 0.33 mM dNTP and either 0.5 or 1 µl (1 x 
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or 2x) Improm-II reverse transcriptase. For miRNA, 100 nM of mSMRT primer was 
used; for mRNA 10 µM random hexamers was used. 
 
Simultaneous Reverse Transcription of miRNA and mRNA 
300 ng of total RNA from BE2C cells was reverse transcribed in the presence of 2.5 
mM MgCl2, 1 x Improm-II buffer (Promega), 0.5 mM dNTP (Bioline), 100 nM 
mSMRT primers and 10 µM of in the presence or absence of random hexamers or 
oligo dT15 using the incubation conditions described above.   
 
Statistical Analyses for miRNA Stability 
The latest available versions of geNorm (version 3.5, 
http://medgen.ugent.be/genorm/) and Normfinder (version 0.953, 
www.mdl.dk/publicationsnormfinder.htm) were downloaded and analyses were 
carried out according to the respective authors’ instructions. Normalization factor 
(NF) deviation from the top ranked genes in each model was determined using the 
following formula: 
 |NFx – NFy| / NFy. 
 
Where NFx was the NF derived from either the overall top ranked genes (miR-106b, 
miR-26b and miR-103 for miRNA study and RPL19/29 for mRNA study), or the 
relative expressions of 5S or snoU6 RNA for miRNA study and either GAPDH or 
ACTB in the mRNA study in that sample and NFy was the geometric mean of the top 
ranked genes by geNorm or Normfinder.  
 
Where Student’s t-test was used, an unpaired two-tailed test was used, with the 
assumption that changes in gene expression is normally distributed [162]. 
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10.1 Appendix A 
ii 
10.2 Appendix B 
    CV 
Gene Primer-Forward Primer-Reverse 
Assay 
Efficiency Intra-Assay  Inter-Assay  
RPL29 ACAGAAATGGCATCAAGAAACCC TCTTGTTGTGCTTCTTGGCAAA 96.4% 15.3% 16.8% 
RPL10a GGTGGCCAAAGTGGATGAGG CATCGGTCATCTTCACGTGG 101.2% 11.8% 12.8% 
LOC292640 GTCCACAGACTGTCCCAGCCAT AGCCCGAGCAAAGTCCTCTG 99.9% 19.8% 21.7% 
LOC498143 ACCAGCTGAAATTTGCCCGA GTGGAATCTTCACCAACCCA 95.9% 16.5% 18.8% 
LOC317275 CCGTCATGCTACCAAGAATAGAGTG TCTAGTTGAGCTGCCGGATGAG 96.0% 8.3% 9.4% 
RPS15 TTCACCTACCGTGGCGTGGA TGAGTGCTGCTTCCTCCGCA 99.0% 15.5% 14.8% 
ARBP GGTCCTGGCTTTGTCTGTGG CAGCCGCAAATGCAGATGGA 99.0% 11.0% 11.0% 
RPL14 GCCAAGATGACAGATTTTGATCG GAGAGCAGCTCTCTGGAGTTTCTTC 98.5% 8.5% 8.7% 
EEF1A1 GATGCTGCCATTGTTGACAT TGTCTGCCTCATGTCACGAA 94.5% 13.3% 14.2% 
RPS15A TCAACAACGCGGAGAAGAGG  CACCAATGTAGCCATGCTTCATC 99.8% 16.0% 17.0% 
RPL18 AAGGGCCGAGAGGTGTACCGACACT TCGAACTTCCGGCCCTTGGA 97.4% 18.8% 20.2% 
REPS1 (P) ACGCAATAAGGAGACCAACA TCCAGTTGAACTTCCAGGGA 96.0% 12.2% 14.1% 
LOC363720 AAAGCCAGGACATCGTGAATCA AGCAGATGGCAAACTTCTGGC 97.2% 9.4% 10.6% 
CNOT8 CCCTTCTGGAATCAACACGT GAACTGCAGCCCTGAGTTGG 95.8% 7.6% 8.9% 
RTCD1 ACGGGACCAGTCACACTCCA GGCATCTTCCTCCTCTTCTG 98.8% 8.2% 9.1% 
RPL19 ACCTGGATGCGAAGGATGAG ACCTTCAGGTACAGGCTGTG 96.2% 12.1% 11.5% 
NDUFB6 (P) CTGGAGCGATTCTGGAATAACTTTT GGTATGATCACATGGGAAACAGTGA 94.2% 12.0% 13.0% 
RPL9 TATCAGGAAGTTTTTGGATGGCATC TCAGGATCTTGTTTCTGAAGCTAGG 98.2% 11.2% 12.2% 
LOC499803 CCTGGGACCCAAGCGGTAAGAT ATGGGGGTGGTGGGCAAGAT 96.6% 19.9% 21.2% 
RPL3 TGGGCAAGATGAGATGATTGACGTC GGGTCTTTCGGGGCAGCTTCTTT 101.0% 13.1% 13.9% 
ACTB GCTATGAGCTGCCTGACGGT GTTTCATGGATGCCACAGGA 92.5% 7.4% 8.3% 
GAPDH ACCACGAGAAATATGACAACTCCC CCAAAGTTGTCATGGATGACC 96.4% 5.0% 4.9% 
EGR1 AAGGGGAGCCGAGCGAACAA GATAACTTGTCTCCACCAGCGCC 90.2% 10.4% 10.8% 
ITGA1 GTCTGAGGTTCTCAAAAGAGGCAC TCACTTGACTCAGGTCGGAAGG 99.6% 5.5% 5.9% 
CRYAB TGCGGGCACCTAGCTGGATT CCTCTGGAGAGAAGTGCTTCACG 97.6% 7.3% 7.8% 
iii 
10.3 Appendix C 
 
  





1 5S CGACGCACACCACCATCGTCGGCCCGA GAACGCGCCCGATCTC CCCTGCTTAGCTTCCGA 88% 0.43% 0.66% 
2 miR-103 
CACGGAACCCGCTCGACCGT
GTCATAG CGCCCGAGCAGCATTGTA CCGCTCGACCGTGTCATAGCC 100% 0.23% 0.35% 
3 miR-106b 
CACGGAACCCCGCCGACCG
TGATCTGC CGCCCGTAAAGTGCTGACAG GCCGACCGTGATCTGCA 100% 0.24% 0.35% 
4 miR-125b 
TGGCGGACCCGCCATCACA
AGT CGACCATCCCTGAGACC GACCCGCCATCACAAGTTAG 98% 0.21% 0.35% 
5 miR-140-5p 
CGAAGAACCCCATCGACTTC
GCTACCA CCGCCAGTGGTTTTACCC CCCATCGACTTCGCTACCATA 100% 0.14% 0.08% 
6 miR-15b 
GAGTGCCCCCACTCTGTAAA
CC AAGCCCGATAGCAGCACATC GCCCCCACTCTGTAAACCAT 99% 0.13% 0.06% 
7 miR-21 TGCCCAACGGGGCATCAACATC AGTGGGGAGTAGCTTATCAGAC CAACGGGGCATCAACATCA 100% 0.23% 0.33% 
8 miR-221 
AGGCGATCCCGCCTGAAAC
CCA CACCCTTGAGCTACATTGTCTG CCCGCCTGAAACCCAG 98% 0.19% 1.93% 
9 miR-23a 
GGCGTGCTCACGCCGGAAA
TCC CTCACCCACATCACATTGCC TCACGCCGGAAATCCCT 100% 0.18% 0.43% 
10 miR-26b 
CCAGGCTCTCCGCCGACCTG
GACCTAT CGCGCCGTTCAAGTAATTCAG CGCCGACCTGGACCTATC 100% 0.26% 0.08% 
11 miR-423 
ACGACCGGGGTCGTACTGA
GGG GGGAAAGCTCGGTCTGAGG GGGGTCGTACTGAGGGG 100% 0.24% 0.08% 
12 miR-425 
CCAGGCACACCACCGACCT
GGTCAACG CGCCCGAATGACACGATCACT CACCGACCTGGTCAACGG 100% 0.24% 0.20% 
13 U6 CACGGAAGCCCTCACACCGTGTCGTTC GCTTCGGCAGCACATATACTAAAAT CTCACACCGTGTCGTTCCA 96% 0.42% 0.48% 
  
iv 
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10.5 Appendix E 
 
SMRTA Excel Formulae and Visual Basic Code for Excel 2003-2010. Customized Visual Basic commands 
are in bold. 
 
To find seed sequence where miRNA sequence is in cell C2 
=LEFT(RIGHT(C2,LEN(C2)-1),7) 
 







' mirna Macro 
' Macro modified 1/8/2010 by Q 
' Modified from JE McGimpsey 
' Originally found on http://www.pcreview.co.uk/forums/thread-1764045.php 
' 
Function revstr(c) 
Dim i As Long 
Dim newstr As String 
i = Len(c) 
For i = i To 1 Step -1 
Select Case UCase(Mid(c, i, 1)) 
Case "A" 
newstr = newstr & "T" 
Case "C" 
newstr = newstr & "G" 
Case "G" 
newstr = newstr & "C" 
Case "U" 
newstr = newstr & "A" 
Case "T" 
newstr = newtr & "A" 
End Select 
Next 
revstr = newstr 
End Function 
 
'Written by Zhou Kang 20 April 2010 
'Accurate for 18-21 nt 
'Validated against (http://www.basic.northwestern.edu/biotools/oligocalc.html) 
'To do : add Mg2+ correction based on Biochem paper 
 
 
Function Tm(Forw As String) 
 
Dim ForwA(1 To 100) As String * 1 
 
A = 0 
T = 0 
vi 
c = 0 
G = 0 
 
N = Len(Forw) 
 
For i = 1 To N 
ForwA(i) = Mid(Forw, i, 1) 
Next i 
 
For i = 1 To N 
    Select Case ForwA(i) 
        Case "A" 
            A = A + 1 
        Case "a" 
            A = A + 1 
        Case "T" 
            T = T + 1 
        Case "t" 
            T = T + 1 
        Case "C" 
            c = c + 1 
        Case "c" 
            c = c + 1 
        Case "G" 
            G = G + 1 
        Case "g" 
            G = G + 1 
    End Select 
Next i 
 










10.6 Appendix F 
 
Development of a Rapid Cell Staining Method Suitable for Automated High 
Content Neurite Quantification 
 
In neuronal cells, molecular events such as gene expression result in dramatic changes in morphology over 
the course of differentiation. Neuronal gene expression plays a role in actively sculpturing the cellular 
ultrastructure into neuron-specific structures. Quantification of neuronal outgrowths was instrumental in 
determination of the physiological functions NGF and continues to be essential to many studies of neuronal 
systems [9]. In response to pro-differentiation factors such as NGF and GFLs, cytoskeleton-regulating 
proteins such as Cdc42 and Rac are actively recruited and give rise to cellular protrusions and eventually 
well-developed processes termed neurites that morphologically mark the cell as a neuron [163, 164]. 
Neurites have been traditionally thought to function primarily as conduits for action potentials and as 
repositories of neurotransmitters. However, recent evidence suggests neurites may also be sites of local 
translation of a sub-population of mRNAs. This ability to realize protein expression in an autonomous, 
decentralized manner has been observed independent of de novo nuclear transcription and soma based 
translation [reviewed in 165]. The level of autonomy and specific molecular control evident in the growth 
and development of neurites makes this a critical aspect of neuronal differentiation.  
 
The regulation of neurite outgrowth has physiological and pathological ramifications  [166]. The effects on 
extension and elaboration of neuronal processes are among the primary measures of drug effects [167], gene 
and growth factor function [17, 164] and disease pathology [168, 169]. Neurite outgrowth may be studied in 
3D, in vivo using sophisticated tracing and imaging techniques [166, 170-172]. However, by far the most 
common approach to routine analysis of neurite outgrowth is through quantitative comparison of 2D 
photomicrographs. Analysis may be through semi- or fully-automated image processing techniques applied 
to these images. Given the heterogeneity of sample populations and images taken of them, automated 
analysis is often only possible through immunochemical or fluorescent staining to increase the contrast of 
the structures of interest against the background.  
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In the light of its fundamental place in neurological studies, it may thus be surprising that many investigators 
continue to use imprecise, subjective measures to classify neurites such as “at least one body length” or 
similar measures [173, 174]. Such approaches render results vulnerable to observer bias and are further 
unable to provide information such as higher-order elaborations of neurite morphology such as, extensive 
branching or self-fasciculation [175-177] which may be of physiological or pathological significance.  
 
Two factors limit widespread use of objective, higher-order neurite quantification. The first is the time and 
labor involved in preparing cell samples for immune-fluorescent methods of imaging, which require long 
periods of incubation and several wash steps. The second is in the methods available for neurite 
quantification, where the choice is between the time and labor involved in semi-manually tracing and 
annotating neurites; or else the significant, if not prohibitory cost of licensing software that is capable of 
accurate, reliable and neurite analysis. These factors are accentuated in studies where in high-throughput 
screening or where statistical robustness is critical. Thus, a method of rapidly staining large samples of cells 
without the need for incubation conditions, coupled with a reliable, automated algorithm for high-content 
neurite quantification would potentially allow many more laboratories to contribute statistically robust 
analyses of neurite outgrowth to the body of knowledge. 
 
The formation, extension and morphological changes of functional neurites has important implications for 
neurological development, motivating widespread study in cell model neuronal systems as a convenient 
alternative to in vivo studies [18, 178, 179]. High content microscopy has the potential to identify subtle 
modulators of neurite outgrowth [180, 181]. Examples of features identified in high content microscopy are 
the number of branches in a neurite or even finer details such as dendritic spine morphology [172]. Neuronal 
function has been intimately tied to modifications of structures in processes such as learning and memory 
[72] and represent a frontier in bridging our understanding of molecular events with macroscopic and 
behavioral phenomena. However, all image data must be appropriately processed in order to provide 
relevant, reliable outputs. Current approaches include commercial software such as HCA-Vision (CSIRO 
Softwre) and freeware such as ImageJ plugins NeuriteTracer and NeuronJ, with further development 
bolstered by rapid advances in computing and image processing algorithms. 
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NeuronJ is a popular plug-in for the NIH funded ImageJ image processing suite and according to a recent 
survey was also the most cited neurite quantification tool [166], and because of its approach of having 
human users manually trace features of interest, can be considered the “gold standard” in accuracy for 
neurite quantification at the level of the individual image. Being supervised, NeuronJ allows the user 
freedom to customize quantification parameters such as neurite branching as appropriate to the study. 
Unfortunately, it also follows that the approach is limited by the need for an excessive level of human 
intervention when dealing with large numbers of images [182]. In contrast, NeuriteTracer requires only 
initial user intervention to define brightness thresholds, but thus also has limited tracing accuracy due to its 
rudimentary feature recognition algorithm and further by its relatively simple analysis of a total neurite 
length in each image [183]. In comparison, HCA-Vision was to be able to accurately quantify fine structural 
details such as neurite branching with only initial user intervention and importantly, store the settings used 
and results obtained for future reference [176]. Initial trials suggested that HCA-Vision but not 
NeuriteTracer had the affordances of necessary for high-content analysis of finer neurite structures such as 
the ability to segment neurites to identify branching events. Other commercial applications such as 
MetaMorph (Molecular Devices) and Neurolucida (MBF Bioscience) were available but not tested as they 
did not have a demonstration version available. A brief demonstration of the tracing performances of 
NeuronJ, HCA-Vision and NeuriteTracer can be found in .  
Comparison of Automated HCA-Vision Tracing to NeuronJ Semi-Automatic 
Tracing 
 
To assess the accuracy of HCA-Vision’s tracing algorithm in our hands, we analysed images of primary 
rodent cortical neurons using both HCA-Vision and manual tracing with NeuronJ (Figure 10.1).  We noticed 
that although on the whole the automated algorithm was able to trace neurites accurately, it also tended to 
segment a neurite into more portions than a human operator. Neurites proceeding directly from the soma are 
considered primary neurites, while secondary and tertiary neurites proceed from primary and secondary 
neurites respectively. A diagram illustrating this delineation can be found at Appendix H. This could arise 
from small pixel gaps in the image that were unnoticeable to the human eye, but which the algorithm 
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compensated for using a branching event. As a result, although the total neurite lengths from automated and 
manual counting differed by slightly less than 10% (~8.9%), the automated algorithm attributed significantly 
more of this length to neurite branches.  
 
Figure 10.1. Automated and manual quantification of neurite outgrowth. Automated quantification resulted in an 
overestimate of branching events.  
 
In order to further test the algorithm’s tracing ability, we also analyzed comparatively complex outgrowth of 
neurites (Figure 10.2). In this test, both automated and manual tracings returned very similar overall length 
results, but with more pronounced differences in neurite segmentation than in the simpler image. While the 
automated algorithm was again able to accurately trace the neurites, the frequent crossing of bright features 
resulted in an overestimation of neurite branching complexity. Thus, while a human operator may 
continuously trace neurites in spite of other features crossing their paths, the algorithm assumed these 
crossing events were branches.  The current version of HCA-Vision thus allows an excellent quantitative 
estimate of overall neurite outgrowth, but conclusions regarding neurite complexity when extensive 




Figure 10.2. Automated and manual quantification of complex neurite outgrowth. Automated quantification resulted in 
significant overestimation of neurite branching events. However, the overall neurite length were very similar to manual 
quantification. 
 
Development of a Rapid Staining Technique Compatible with Automated 
Neurite Quantification 
 
Current protocols for quantification of neurites recommend or require cell fixation and subsequent 
fluorescent staining, usually through ICC to enable feature differentiation and thus accurate neurite tracing 
[175, 182, 183].  ICC is able to highlight a specific population of cells from a heterogenous population (for 
example, neurons in a primary culture of the cortex) or a subcellular component within cells based on 
immunogenicity. However, scaling current ICC approaches for high-throughput screening would require an 
inordinate amount of time, labour and costs as due to multiple incubations at controlled temperatures 
necessary. In neurons, for cases where neurite quantification but not lineage specification is desired (for 
example in cultures of PC12 cells) a less discriminative, quickly applied stain would provide a facile 
alternative to ICC. A recent review on the subject revealed little or no interest in the development of 
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alternatives to the traditional method of fluorescence-labeled ICC for neurite tracing applications [166]. 
NeuronJ [184-186], NeuriteTracer [74] and HCA-Vision [176] have been used in literature on images 
stained with ICC only. It is thus unclear how inputs other than ICC-derived images will perform with neurite 
quantification algorithms. 
 
We noticed that many studies of neurites involved cell culture experiments using neurite-extending cells 
such as neuroblastoma or pheochromocytoma cells or nearly pure cultures of primary neurons. As such, it 
may not be strictly necessary for the staining technique to distinguish different cell types. A non-specific 
stain capable of producing sufficient contrast against the background may therefore be a sufficient substitute 
for immunocytochemistry for these applications. Protein stains are an attractive alternative to antibody-
based detection as proteins are distributed throughout cells and available in most laboratories. Initial studies 
were carried out in the context of finding stains suitable for visualization using a fluorescence microscopy 
set-up capable of visualizing only green and red fluorescence.  
 
Sulforhodamine B (SRB, also known as kiton red) is a fluorescent protein stain that is commonly used for 
cell proliferation assays. It binds to proteins via electrostatic interactions and emits a strong fluorescence 
signal at 613nm.  It seemed to be an attractive option due to its relatively low cost and strong fluorescence. 
Unfortunately, SRB was also highly soluble in water and did not associate very strongly with cellular 
proteins. This resulted in both a high level of background fluorescence when cells were imaged under 
aqueous buffers as well as a loss of stain even under gentle washing conditions. The red fluorescence spilled 
over into the green channel and hence SRB is not suitable for use with SYBR Green I nuclear staining. We 
hypothesized that using the blue channel and a suitable dye such as a Hoechst stain may circumvent the 
fluorescent spillover. However, high background fluorescence arising from the relatively weak association 
between SRB and the cells rendered it an unsuitable choice as automated neurite quantification algorithms 
may interpret background signals as neurite extensions in an unpredictable manner. The background 
fluorescence would also interfere with the algorithms’ recognition of cell bodies, which is highly dependent 




Figure 10.3. Performance of SRB stain. SRB exhibited a significant emission in the green channel, which ideally should have 
been reserved for fluorescence from the DNA-binding nuclear stain (SYBR Green I). SRB also easily dissociated from cellular 
proteins, resulting in significant background fluorescence form the buffer in the red channel. 
 
The Imperial Protein Stain (Pierce, Rockford, IL) is a R-250 Commassie based stain that after 
permeabilization and fixation did not require additional methanol/acetic acid washes. We found that this 
stain could be quickly applied to formalin-fixed cells, with cells being strongly stained after 15 – 30 min of 
incubation at room temperature (Figure 10.4). Excess dye could be easily removed with PBS while cell 
bodies and neurites retained the stain well. Importantly, we found that the stain did not interfere with SYBR 
Green I fluorescence. This made the staining approach potentially compatible with automated quantification 
algorithms which required clear demarcation of both nuclei and neurites. 
 
Figure 10.4. Imperial stain incubation times. Formalin-fixed N1E-115 cells were incubated with neat Imperial stain for A) 5 
min B) 15 min C) 30 min at room temperature and washed twice with PBS.  
 
 
We applied this approach of using the Imperial/SYBR Green I stain to primary rat cortical cultures and 
analyzed the resulting images using the automated algorithms in HCA-Vision and NeuriteTracer to 
determine if the contrast achieved using bright-field micrographs could be sufficient for quantification 
algorithms designed for dark-field, low-noise fluorescence images (Figure 10.5).  
 
Green channel Red channel Visible 
A B C 
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Figure 10.5. Imperial/SYBR Green I stain was compatible with automated neurite tracing algorithms. Primary rat cortical 
neurons were imaged using A) bright-field. The dotted line indicates the user-defined border, beyond which the algorithm would 
ignore cell bodies. B) SYBR Green I fluorescence indicating the presence of nuclei and therefore cell bodies. C) Automated 
neurite tracing using HCA-Vision. Speckles in the bright-field micrograph were removed from quantification by HCA-Vision’s 
proprietary image processing suite. D) The same bright-field image processed by NeuriteTracer. It is clear that non-specific 
staining would cause spurious tracings. 
 
This method proved amenable to automated analysis by using in tandem HCA-Vision’s image processing 
and neurite tracing algorithms. In contrast, NeuriteTracer’s more rudimentary image processing rendered it 
unable to adequately account for image noise such as speckles caused by the non-specific staining. 
 
Even at this preliminary stage, the Imperial/SYBR Green I staining approach delineated affords significant 
savings in time and labor (Figure 10.6). As non-fluorescent protein stains and DNA-binding dyes for nuclear 
staining are generally inexpensive, this approach also represents a reduction in reagent costs that would be 
particularly significant in the context of high-throughput studies. The approach outlined above can easily be 
adapted to available reagents with similar qualities if reagent or equipment availability so dictate. For 
example, we have found that the Imperial stain approach is compatible with Hoechst staining, potentially 







Figure 10.6. Comparison between ICC and Imperial/SYBR Green I Approach. The Imperial/SYBR Green I approach can be 
completed under room temperature conditions in less than 1 h after cell fixation. In comparison, ICC for each sample requires at 





These studies represent preliminary efforts to develop a robust, scalable and economical approach to neurite 
quantification. There remains extensive testing and refinement to be done before such time that these 
methods can fully support high-throughput usage. However, these results serve as a proof-of-concept and a 
paradigm shift from being restricted to the use of fluorescent ICC-based methods for neurite quantification. 
The time, labor and reagent costs were significantly reduced compared to ICC-based methods and yet were 
still amenable to automated neurite quantification algorithms. Further optimization of the staining and 
destaining parameters may improve the compatibility of this staining approach with simpler image 
processing algorithms such as NeuriteTracer. However, given the rapid progress in computing power and 
increasing algorithmic sophistication, mitigation of the relatively high level of noise produced in bright-field 
micrographs to levels where signal-noise ratio is comparable to dark-field fluorescence micrographs could 











10.7 Appendix G 
 
Cultured cortical rat neurons were fixed and visualized using fluorescently labeled Tuj-1 antibodies. A) 
Original fluorescence photomicrograph. B) Image analyzed with HCA-Vision. The feature recognition 
algorithm was able to differentiate cells and spatially assign neurites to their parent cell. C) NeuriteTracer 
was able to trace neurites accurately, but often added spurious branches as a result of background signal. D) 
NeuronJ allows accurate tracing of features visible to human eye, but requires a significant amount of time 
and intervention. Tracing an image of the complexity shown here took an average of 3 min. In comparison, 










Neurite segmentation in HCA-Vision and NeuronJ.  Neurites proceeding directly from the soma are 
considered primary neurites, while secondary and tertiary neurites proceed from primary and secondary 
neurites respectively. 
 
HCA Legend : PRIMARY      SECONDARY     TERTIARY 
NeuronJ Legend:PRIMARY ||SECONDARY|| TERTIARY 
HCA-Vision 
NeuronJ 
